Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Regulation of Microtubule Cytoskeleton WP2038,0.004278903444695249,2.5630936061881915,13.97926248636283,"['GSK3B', 'TRIO', 'PTEN', 'TESK2', 'CDC42', 'PAK1', 'CLIP1', 'PIK3CA', 'DPYSL2', 'RHO', 'CDK1', 'RAC1', 'MAPT', 'PRKACA', 'PHLDB2']",0.98799492372058,0,0,15
2,Mitochondrial CII Assembly WP4920,0.0054875897067835485,7.961065573770492,41.439465174846454,"['SDHAF2', 'SDHAF4', 'SDHC', 'SDHD', 'SDHB']",0.98799492372058,0,0,5
3,Chemokine signaling pathway WP3929,0.007043941058877438,1.7188943028485757,8.51813104529591,"['ITK', 'GSK3B', 'PXN', 'PIK3R3', 'PIK3CD', 'ADCY1', 'ADCY8', 'ADCY7', 'CDC42', 'PAK1', 'RAP1A', 'AKT3', 'RAC2', 'RAC1', 'JAK2', 'JAK3', 'VAV3', 'PRKCB', 'STAT1', 'PRKCD', 'BRAF', 'NFKB1', 'VAV1', 'NFKBIA', 'PLCB3', 'ADCY9', 'PLCB4', 'PIK3CA', 'GNB1', 'GNB5', 'SOS1', 'SOS2', 'NFKBIB']",0.98799492372058,0,0,33
4,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.01059254800996868,5.970372267759563,27.150892048411364,"['MESP2', 'HES7', 'EPHA4', 'RIPPLY2', 'DLL1']",0.98799492372058,0,0,5
5,Neural Crest Cell Migration in Cancer WP4565,0.01178511798991447,2.4945596356221067,11.078134116302131,"['ARF1', 'PAK1', 'TRIO', 'PIK3CA', 'SORT1', 'AKT3', 'PIK3R3', 'PIK3CD', 'RAC1', 'FOS', 'RHOA', 'NGEF']",0.98799492372058,0,0,12
6,Non-small cell lung cancer WP4255,0.013386347052877655,1.9140405080672847,8.256251951269581,"['ALK', 'PRKCG', 'PRKCB', 'PIK3CD', 'PIK3R3', 'TGFA', 'BRAF', 'STK4', 'CASP9', 'RXRB', 'RASSF1', 'PIK3CA', 'AKT3', 'ERBB2', 'E2F1', 'E2F3', 'SOS1', 'JAK3', 'SOS2', 'PDK1']",0.98799492372058,0,0,20
7,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.015037748215110381,2.8674418604651164,12.035203152344167,"['NFKBIA', 'GSK3B', 'ITK', 'ZAP70', 'PTEN', 'DYRK1A', 'RASGRP1', 'NFKB1', 'PDK1']",0.98799492372058,0,0,9
8,Neural Crest Cell Migration during Development WP4564,0.01528682590507632,2.503960105602816,10.468465950083615,"['ARF1', 'PAK1', 'TRIO', 'PIK3CA', 'AKT3', 'PIK3R3', 'PIK3CD', 'RAC1', 'FOS', 'RHOA', 'NGEF']",0.98799492372058,0,0,11
9,Gene regulatory network modelling somitogenesis  WP2854,0.018190689091395817,4.775956284153006,19.13651848777187,"['MESP2', 'HES7', 'EPHA4', 'RIPPLY2', 'DLL1']",0.98799492372058,0,0,5
10,16p11.2 proximal deletion syndrome WP4949,0.019825040327834692,1.8549437619934728,7.272881081831307,"['CCT3', 'IGBP1', 'INO80E', 'PRRT2', 'DOC2A', 'PTEN', 'TRAF2', 'KIF22', 'NR3C1', 'NFKB1', 'PAGR1', 'PPP2CB', 'HIRIP3', 'ASPHD1', 'PPP4R4', 'TRAF6', 'KCTD13', 'CCDC6', 'PPARG']",0.98799492372058,0,0,19
11,Cell migration and invasion through p75NTR WP4561,0.0199616080450997,2.6880343707250343,10.520817201230614,"['ARF1', 'PAK1', 'TRIO', 'EFNB3', 'EFNA2', 'AKT3', 'RAC1', 'EFNA5', 'RHOA']",0.98799492372058,0,0,9
12,Prolactin Signaling Pathway WP2037,0.02117131979401243,1.8053099637927572,6.959664618739196,"['ITGB1', 'GSK3B', 'IRS1', 'STAT1', 'PXN', 'AGAP2', 'FOS', 'YWHAZ', 'VAV1', 'NFKB1', 'NFKBIA', 'ZAP70', 'PAK1', 'PIK3CA', 'RPS6KA2', 'ERBB2', 'RAC1', 'JAK2', 'SOS1', 'NFKBIB']",0.98799492372058,0,0,20
13,PDGF Pathway WP2526,0.028325208138967797,2.1243866255848456,7.571320569855076,"['CDC42', 'PDGFRB', 'NFKBIA', 'MAP2K4', 'PAK1', 'STAT1', 'RAC1', 'FOS', 'SOS1', 'NFKB1', 'RHOA', 'VAV1']",0.9967659009132112,0,0,12
14,Purine metabolism WP4792,0.0286618092876274,3.979678961748634,14.136574733471683,"['DGUOK', 'ADSL', 'ATIC', 'HPRT1', 'ITPA']",0.9967659009132112,0,0,5
15,Aspirin and miRNAs WP4707,0.03496711696089518,4.774667121884602,16.01111650243067,"['ABCC4', 'PTGS2', 'NFKB1', 'PDK1']",0.9967659009132112,0,0,4
16,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.03496711696089518,4.774667121884602,16.01111650243067,"['TRAF6', 'UBE2V1', 'SQSTM1', 'NFKB1']",0.9967659009132112,0,0,4
17,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.042267459434771164,3.4109094457455114,10.791223041780666,"['IL11', 'ZEB1', 'JAK2', 'JAK3', 'NFKB1']",0.9967659009132112,0,0,5
18,Canonical and non-canonical Notch signaling WP3845,0.0434833995611793,2.3885470085470084,7.488993044306235,"['DLL4', 'MAML2', 'HEY1', 'MFAP1', 'PSEN2', 'ADAM10', 'DLL1', 'DLK2']",0.9967659009132112,0,0,8
19,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.04475376108077781,1.8828144458281444,5.849113308168297,"['PPP1R16B', 'PPP1R10', 'EIF2AK1', 'EIF2AK3', 'PPP1R3A', 'EIF2S1', 'PPP1R2', 'PPP1R1A', 'PPP1R7', 'PPP1R3E', 'PPP1R8', 'PPP1R12C', 'ATF4']",0.9967659009132112,0,0,13
20,Overview of interferons-mediated signaling pathway WP4558,0.04475817168251867,2.8655278442090877,8.901708500766519,"['PIK3CA', 'STAT1', 'IFNGR2', 'IFNE', 'JAK2', 'IFNAR1']",0.9967659009132112,0,0,6
21,Disruption of postsynaptic signaling by CNV WP4875,0.0477877795424159,2.0773773222865133,6.3172739625281515,"['RPH3A', 'TJP1', 'RYR2', 'CYFIP1', 'DLG1', 'SYNGAP1', 'NLGN4X', 'NRXN1', 'CAMK2A', 'STX1A']",0.9967659009132112,0,0,10
22,Glycosylation and related congenital defects WP4521,0.05455248748516325,2.2478833584715936,6.538175480660218,"['ALG8', 'ALG6', 'MPI', 'SRD5A3', 'ALG14', 'ALG3', 'MAGT1', 'ALG11']",0.9967659009132112,0,0,8
23,Ras signaling WP4223,0.054995095481473896,1.3894796619417196,4.030201419995341,"['PIK3R3', 'PIK3CD', 'RASAL2', 'PLA2G6', 'STK4', 'RASGRP1', 'IGF1R', 'CDC42', 'RASSF1', 'PAK1', 'SYNGAP1', 'RAP1A', 'AKT3', 'RAC2', 'ABL2', 'RAC1', 'PRKACA', 'PDGFRB', 'PRKCG', 'PRKCB', 'PLA2G4C', 'GAB1', 'NFKB1', 'RHOA', 'MAPK10', 'AFDN', 'ZAP70', 'MRAS', 'PIK3CA', 'GNB1', 'GNB5', 'RGL1', 'SOS1', 'RAPGEF5', 'RAB5A', 'SOS2']",0.9967659009132112,0,0,36
24,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.05605888267164204,1.4177486690413268,4.085033904965764,"['CYFIP1', 'GSK3B', 'IRS1', 'CAMK2A', 'ACACB', 'PTPRF', 'CDC42', 'GRIP1', 'RPS6KA5', 'RAP1A', 'DPYSL2', 'RAC1', 'JAK2', 'SH2B1', 'VAV3', 'EGR2', 'CSNK2A1', 'STAT1', 'SORT1', 'PRKCD', 'FOS', 'EIF2S2', 'EIF2S1', 'NFKB1', 'NFKBIA', 'MAPK10', 'DLG1', 'DOK5', 'TRAF6', 'ALPL', 'MAPT', 'SQSTM1']",0.9967659009132112,0,0,32
25,3q29 copy number variation syndrome WP4906,0.05803261067910682,1.7070155683932242,4.8594468652391924,"['TM4SF19', 'DYNLT1', 'DYNLT3', 'CEP350', 'PXN', 'RNF8', 'PIGZ', 'ADAM10', 'PIK3R3', 'WDR53', 'DYNLL2', 'DLG1', 'DYNLRB2', 'NF2', 'MELTF']",0.9967659009132112,0,0,15
26,Major receptors targeted by epinephrine and norepinephrine WP4589,0.059142179641901646,2.9843323087431695,8.439127460559309,"['ADCY9', 'ADRA1D', 'ADCY1', 'ADCY8', 'ADCY7']",0.9967659009132112,0,0,5
27,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.05933586860059204,2.604838960151567,7.357475194267833,"['EIF2S3', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF2S1', 'EIF3D']",0.9967659009132112,0,0,6
28,Pancreatic adenocarcinoma pathway WP4263,0.05953034035665302,1.5448224852071006,4.358360057490439,"['STAT1', 'PRKCD', 'PEBP1', 'PIK3CD', 'PIK3R3', 'TGFA', 'BRAF', 'RHOA', 'NFKB1', 'CASP9', 'CDC42', 'MAPK10', 'PAK1', 'PIK3CA', 'AKT3', 'ERBB2', 'RAC2', 'E2F1', 'E2F3', 'RAC1', 'ARHGEF6']",0.9967659009132112,0,0,21
29,Small cell lung cancer WP4658,0.06021799405263278,1.5246516212865742,4.283941832914299,"['ITGB1', 'LAMA5', 'LAMA1', 'PTEN', 'PIK3CD', 'PIK3R3', 'TRAF2', 'LAMC1', 'TRAF1', 'PTGS2', 'NFKB1', 'CASP9', 'RXRB', 'NFKBIA', 'PIK3CA', 'TRAF6', 'AKT3', 'TRAF5', 'E2F1', 'ITGAV', 'E2F3', 'NFKBIB']",0.9967659009132112,0,0,22
30,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.06543261534585622,1.5422521953866428,4.205312175149874,"['PRKCG', 'PDGFRB', 'GSK3B', 'PRKCB', 'PTEN', 'GAB1', 'PIK3CD', 'PIK3R3', 'TGFA', 'NRG1', 'BRAF', 'IGF1R', 'MRAS', 'PIK3CA', 'AKT3', 'ERBB2', 'JAK2', 'EIF4E2', 'SOS1', 'SOS2']",0.9967659009132112,0,0,20
31,Focal Adhesion WP306,0.06632479203295137,1.3387511209840972,3.632288181533364,"['ITGB1', 'GSK3B', 'LAMA5', 'LAMA1', 'PXN', 'TNC', 'PTEN', 'TESK2', 'PIK3R3', 'PIK3CD', 'LAMC1', 'IGF1R', 'CDC42', 'PAK1', 'CCND2', 'RAP1A', 'AKT3', 'ERBB2', 'RAC2', 'ITGB8', 'ITGAV', 'RAC1', 'PRKCG', 'VASP', 'VAV3', 'PDGFRB', 'PRKCB', 'VEGFC', 'BRAF', 'PARVB', 'RHOA', 'VAV1', 'MAPK10', 'MYL5', 'MYL7', 'PIK3CA', 'ITGA10', 'ITGA8', 'SOS1', 'PPP1R12C']",0.9967659009132112,0,0,40
32,Ciliary landscape WP4352,0.07137415836239663,1.305464618484009,3.4461908296027257,"['ECHS1', 'PSMD13', 'UBE2D2', 'MCM9', 'CAMK2A', 'COPS7B', 'MCM10', 'RPGR', 'EXOSC7', 'RMND5B', 'PGRMC2', 'ARHGDIA', 'BBS9', 'CEP170', 'RAC1', 'SNAP29', 'RAB8A', 'BBS4', 'RAB2A', 'EIF5B', 'CNOT6L', 'DYNLT1', 'IFT140', 'EIPR1', 'DYNLT3', 'EXOC6B', 'DYNLL2', 'NFKB1', 'AIMP1', 'COPS4', 'IFT20', 'AFG3L2', 'MKLN1', 'COPS3', 'IFT22', 'TBC1D4', 'MFAP1', 'WNK1', 'TIPRL', 'IFT27', 'MCM4', 'DYNLRB2', 'EFHC2', 'CNOT9', 'PAFAH1B1']",0.9967659009132112,0,0,45
33,Fatty Acid Biosynthesis WP357,0.07209706011791218,2.228708133971292,5.860927409239462,"['MECR', 'ECHS1', 'ACSS2', 'ECH1', 'ACACB', 'ACACA', 'DECR1']",0.9967659009132112,0,0,7
34,Zinc homeostasis WP3529,0.07487731194341679,1.9540946399701529,5.064826389147481,"['SLC30A9', 'SLC30A3', 'SLC39A9', 'SLC30A4', 'SLC39A10', 'SLC39A7', 'SLC39A1', 'SLC39A4', 'SLC39A3']",0.9967659009132112,0,0,9
35,Apoptosis Modulation by HSP70 WP384,0.07641188953855735,2.3875982234369664,6.139988115343342,"['CASP9', 'MAPK10', 'CASP6', 'CASP2', 'NFKB1', 'HSPA1A']",0.9967659009132112,0,0,6
36,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.07641188953855735,2.3875982234369664,6.139988115343342,"['MDH2', 'IDH2', 'SDHC', 'SDHD', 'SDHB', 'DLD']",0.9967659009132112,0,0,6
37,Non-homologous end joining WP438,0.0786508949872063,3.1826561966541482,8.092655346731947,"['XRCC6', 'XRCC4', 'XRCC5', 'POLL']",0.9967659009132112,0,0,4
38,Joubert Syndrome WP4656,0.07925330957629305,1.536351384464592,3.8948137755359413,"['PARP1', 'CETN2', 'ARL3', 'RHOA', 'TMEM231', 'AHI1', 'NIN', 'TMEM17', 'TCTN3', 'TMEM138', 'CSPP1', 'TCTN1', 'BBS9', 'B9D1', 'CEP41', 'RAB8A', 'BBS4', 'ATF4']",0.9967659009132112,0,0,18
39,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.0792960280852828,2.6525500910746813,6.723066560094423,"['ITGB1', 'ZEB2', 'TERT', 'NRG3', 'ALPL']",0.9967659009132112,0,0,5
40,Mitochondrial complex I assembly model OXPHOS system WP4324,0.08050353032621863,1.6787856349500185,4.2296235869242995,"['COA1', 'DMAC1', 'NDUFB6', 'DMAC2', 'ACAD9', 'ECSIT', 'TMEM186', 'FOXRED1', 'NDUFS1', 'TMEM126B', 'NDUFV3', 'NDUFAF1', 'NDUFV1']",0.9967659009132112,0,0,13
41,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.08078548501969539,1.8372851917155715,4.622532322064116,"['PRKCG', 'KISS1', 'PLCB3', 'PLCB4', 'PIK3CA', 'PRKCB', 'PRKCD', 'PIK3CD', 'NFKB1', 'PDK1']",0.9967659009132112,0,0,10
42,DNA damage response (only ATM dependent) WP710,0.08104082771042477,1.446911738108157,3.6358030066681297,"['WNT10B', 'GSK3B', 'WNT10A', 'IRS1', 'PTEN', 'PIK3R3', 'PIK3CD', 'HMGB1', 'NFKB1', 'RHOA', 'CDC42', 'MAPK10', 'CCND2', 'PIK3CA', 'AKT3', 'CAT', 'ERBB2', 'RAC2', 'RAC1', 'SOS1', 'SOS2', 'MAP3K4', 'PDK1']",0.9967659009132112,0,0,23
43,Intraflagellar transport proteins binding to dynein WP4532,0.08164932501997763,2.0109761583445795,5.038142260669361,"['IFT22', 'DYNC1LI2', 'DYNLT1', 'IFT140', 'DYNLT3', 'IFT27', 'DYNLRB2', 'DYNLL2']",0.9967659009132112,0,0,8
44,miRNA regulation of prostate cancer signaling pathways WP3981,0.08884086799818772,1.8690001784333552,4.524678436507302,"['CASP9', 'PDGFRB', 'NFKBIA', 'GSK3B', 'PIK3CA', 'CREB3L1', 'AKT3', 'SOS1', 'NFKB1']",0.9967659009132112,0,0,9
45,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.08892611320691661,1.686167106349558,4.080439149366676,"['MAPK10', 'MAP2K4', 'RPS6KA5', 'CSNK2A1', 'PIK3CA', 'RPS6KA2', 'AKT3', 'PRKCD', 'PIK3R3', 'PRKACA', 'EIF4G3', 'PDK1']",0.9967659009132112,0,0,12
46,Translation Factors WP107,0.09165864199479377,1.6344899062725307,3.9059144028272015,"['EIF5B', 'EIF2AK1', 'EIF2AK3', 'EIF2S2', 'EIF2S1', 'EEF1A1', 'EIF2S3', 'EIF3J', 'ETF1', 'EIF3F', 'EIF2B1', 'EIF3D', 'EIF4G3']",0.9967659009132112,0,0,13
47,Nucleotide metabolism WP404,0.09596160742682695,2.2037791385246117,5.165233169980805,"['PRPS2', 'ADSL', 'RRM2', 'POLD1', 'HPRT1', 'SRM']",0.9967659009132112,0,0,6
48,PDGFR-beta pathway WP3972,0.0977063157223969,1.9102905982905982,4.442933009283462,"['PDGFRB', 'MAP2K4', 'PIK3CA', 'STAT1', 'PRKCB', 'FOS', 'JAK2', 'SOS1']",0.9967659009132112,0,0,8
49,Alpha 6 Beta 4 signaling pathway WP244,0.10423578272242816,1.7909969220246238,4.04962279001117,"['LAMA5', 'LAMA1', 'IRS1', 'PRKCD', 'GAB1', 'LAMC1', 'RAC1', 'SOS1', 'RHOA']",0.9967659009132112,0,0,9
50,Melatonin metabolism and effects WP3298,0.10423578272242816,1.7909969220246238,4.04962279001117,"['SULT1A1', 'GSK3B', 'AANAT', 'PER3', 'TRAF6', 'CAMK2A', 'CRY2', 'CLOCK', 'NFKB1']",0.9967659009132112,0,0,9
51,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.10532080549478191,3.579778156996587,8.057165268925232,"['HEY1', 'VEGFC', 'HIF1AN']",0.9967659009132112,0,0,3
52,Pentose Phosphate Metabolism WP134,0.10532080549478191,3.579778156996587,8.057165268925232,"['G6PD', 'TALDO1', 'PGLS']",0.9967659009132112,0,0,3
53,MET in type 1 papillary renal cell carcinoma WP4205,0.10535693848598149,1.555518375996877,3.500540543814911,"['ALK', 'GAB1', 'PIK3CD', 'PIK3R3', 'BRAF', 'CDC42', 'PAK1', 'RAP1A', 'PIK3CA', 'AKT3', 'RAC1', 'SOS1', 'JAK3', 'SOS2']",0.9967659009132112,0,0,14
54,Farnesoid X receptor pathway WP2879,0.1072161059899954,2.7277959323025898,6.0909195396241795,"['ABCB4', 'ABCB11', 'SLC27A5', 'FKBP5']",0.9967659009132112,0,0,4
55,ErbB signaling pathway WP673,0.10722866388431655,1.42664637676704,3.185404159072739,"['PRKCG', 'GSK3B', 'MAP2K4', 'PRKCB', 'CAMK2A', 'GAB1', 'PIK3CD', 'PIK3R3', 'TGFA', 'NRG1', 'BRAF', 'MAPK10', 'PAK1', 'NRG3', 'PIK3CA', 'AKT3', 'ERBB2', 'ABL2', 'SOS1', 'SOS2']",0.9967659009132112,0,0,20
56,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.10754567407090267,1.4412850933098016,3.213834643072701,"['GSK3B', 'THRA', 'ITPR2', 'SIRT6', 'TTF2', 'TTF1', 'ADCY8', 'CASP9', 'TBC1D4', 'PIK3CA', 'NPY', 'AKT3', 'NPPA', 'ITGAV', 'PPARG', 'PRKACA', 'SOS1', 'MAP4K5', 'MGLL']",0.9967659009132112,0,0,19
57,Hepatitis B infection WP4666,0.10854947474663967,1.338698795180723,2.972646567440753,"['PIK3R3', 'PIK3CD', 'CASP9', 'CREB3L4', 'CREB3L1', 'AKT3', 'CREB3L2', 'JAK2', 'JAK3', 'PRKCG', 'MAP2K4', 'EGR2', 'PRKCB', 'STAT1', 'BRAF', 'FOS', 'YWHAZ', 'NFKB1', 'DDB1', 'MAPK10', 'PIK3CA', 'TRAF6', 'TAB2', 'SOS1', 'SOS2', 'IFNAR1', 'ATF4', 'CREB5']",0.9967659009132112,0,0,28
58,Phosphoinositides metabolism WP4971,0.11496951053373175,1.5922629236562822,3.44420531909855,"['MTMR10', 'PLCB3', 'MTMR2', 'PLCB4', 'MTMR3', 'PIK3CA', 'INPP5D', 'PTEN', 'MTMR8', 'PIK3CD', 'PIP5K1B', 'MTM1']",0.9967659009132112,0,0,12
59,Integrin-mediated Cell Adhesion WP185,0.11641828341419731,1.3939302884615385,2.9977386414859546,"['VASP', 'ITGB1', 'VAV3', 'PXN', 'BRAF', 'ITGAE', 'CDC42', 'MAPK10', 'PAK1', 'RAP1A', 'CAPNS1', 'CAPN7', 'ITGA10', 'AKT3', 'RAC2', 'ITGA8', 'RHO', 'ITGB8', 'ITGAV', 'RAC1', 'SOS1']",0.9967659009132112,0,0,21
60,Globo Sphingolipid Metabolism WP1424,0.1178990151967192,2.0462199228854505,4.374668461641695,"['B3GALNT1', 'ST6GAL2', 'ST8SIA1', 'B3GALT5', 'FUT2', 'ST6GALNAC3']",0.9967659009132112,0,0,6
61,Hippo-Yap signaling pathway WP4537,0.1178990151967192,2.0462199228854505,4.374668461641695,"['RASSF1', 'NF2', 'TNIK', 'NDRG1', 'TEAD1', 'MAP4K3']",0.9967659009132112,0,0,6
62,Purine metabolism and related disorders WP4224,0.1178990151967192,2.0462199228854505,4.374668461641695,"['DGUOK', 'ADSL', 'GRM5', 'ATIC', 'HPRT1', 'ITPA']",0.9967659009132112,0,0,6
63,DNA Repair Pathways Full Network WP4946,0.11974321722074503,1.3363960185092714,2.836374507707732,"['WDR48', 'MPG', 'CETN2', 'HMGB1', 'RAP1A', 'POLD1', 'CHEK1', 'REV3L', 'POLL', 'XRCC6', 'XRCC4', 'PARP1', 'XRCC5', 'RFC2', 'REV1', 'APEX2', 'LIG3', 'FANCC', 'GTF2H3', 'RBX1', 'FANCF', 'DDB1', 'CDK7', 'ERCC3', 'ERCC2', 'ERCC8']",0.9967659009132112,0,0,26
64,Signaling of Hepatocyte Growth Factor Receptor WP313,0.12103884107926027,1.719233926128591,3.6304096337640392,"['ITGB1', 'PAK1', 'RAP1A', 'PIK3CA', 'PXN', 'PTEN', 'GAB1', 'FOS', 'SOS1']",0.9967659009132112,0,0,9
65,Photodynamic therapy-induced unfolded protein response WP3613,0.12796401689758988,1.8568580542264752,3.81771162107812,"['DNAJC3', 'WARS', 'DNAJB11', 'EIF2AK3', 'CALR', 'PDIA6', 'ATF4']",0.9967659009132112,0,0,7
66,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.12892854912749135,2.169957774465971,4.445151797566051,"['RPH3A', 'SYTL1', 'GCC2', 'SYTL2', 'EXPH5']",0.9967659009132112,0,0,5
67,MAPK pathway in congenital thyroid cancer WP4928,0.12892854912749135,2.169957774465971,4.445151797566051,"['ALK', 'BRAF', 'FOS', 'SOS1', 'SOS2']",0.9967659009132112,0,0,5
68,NAD+ metabolism WP3644,0.12892854912749135,2.169957774465971,4.445151797566051,"['NT5E', 'PARP1', 'SIRT5', 'SIRT6', 'NADK']",0.9967659009132112,0,0,5
69,Gastrin signaling pathway WP4659,0.13402057872492554,1.3404618221439946,2.6940091230106122,"['ITGB1', 'GSK3B', 'IRS1', 'PRKCD', 'PXN', 'PIK3R3', 'FOS', 'PTGS2', 'NFKB1', 'RHOA', 'RHOB', 'NFKBIA', 'CDC42', 'TJP1', 'PAK1', 'CCKBR', 'PIK3CA', 'TCF4', 'PPARG', 'RAC1', 'PRKACA', 'JAK2', 'SOS1']",0.9967659009132112,0,0,23
70,B Cell Receptor Signaling Pathway WP23,0.1388375627123075,1.3652101417291942,2.695540041885084,"['GSK3B', 'PTPN18', 'CD81', 'PRKCB', 'PRKCD', 'CAMK2A', 'GAB1', 'BRAF', 'ILF2', 'NFKB1', 'VAV1', 'NFKBIA', 'CDC42', 'INPP5D', 'RAC2', 'PIP5K1B', 'E2F3', 'RAC1', 'SOS1', 'PIK3AP1']",0.9967659009132112,0,0,20
71,NO metabolism in cystic fibrosis WP4947,0.13969044380896822,2.386650734038921,4.697707695476003,"['PRMT6', 'PRMT5', 'PRMT8', 'PRMT2']",0.9967659009132112,0,0,4
72,Common Pathways Underlying Drug Addiction WP2636,0.14214765668379326,1.5918576804652753,3.105537520323945,"['PRKCG', 'GRM5', 'RAP1A', 'PPP1R1A', 'PRKCB', 'CAMK2A', 'ADCY1', 'DRD1', 'ADCY8', 'PRKACA']",0.9967659009132112,0,0,10
73,Nephrotic syndrome WP4758,0.14214765668379326,1.5918576804652753,3.105537520323945,"['CUBN', 'ANLN', 'INF2', 'NPHS1', 'PODXL', 'ARHGDIA', 'TTC21B', 'MYH9', 'E2F3', 'CD2AP']",0.9967659009132112,0,0,10
74,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.14465078366820303,1.4330705962988348,2.77074573843306,"['SEC13', 'SEC24B', 'SAR1A', 'NFYA', 'PRKAG1', 'LPL', 'LSS', 'ACACA', 'CDK8', 'RBP4', 'PIK3CA', 'PPARG', 'PRKACA', 'SEC24D', 'SEC23B']",0.9967659009132112,0,0,15
75,PI3K-Akt signaling pathway WP4172,0.1457425939558751,1.1903902884866258,2.292588451148685,"['ITGB1', 'GSK3B', 'HSP90AB1', 'IRS1', 'TNC', 'PTEN', 'PIK3CD', 'LAMC1', 'FGF1', 'IGF1R', 'GYS2', 'CASP9', 'CCND2', 'CREB3L4', 'CREB3L1', 'MYB', 'CREB3L2', 'AKT3', 'ITGB8', 'ITGAV', 'RAC1', 'JAK2', 'JAK3', 'PDGFRB', 'HSP90AA1', 'PPP2R5A', 'PIK3CA', 'ITGA8', 'EIF4E2', 'SOS1', 'SGK2', 'SOS2', 'ATF4', 'IFNAR1', 'CREB5', 'LAMA5', 'LAMA1', 'TGFA', 'PIK3R3', 'LPAR2', 'EFNA5', 'PPP2CB', 'FGF22', 'VEGFC', 'NFKB1', 'EFNA2', 'FGF14', 'ITGA10', 'GNB1', 'PKN2', 'GNB5', 'PIK3AP1', 'FGF12', 'FGF10']",0.9967659009132112,0,0,54
76,Thermogenesis WP4321,0.14650244097818027,1.330701094495345,2.5558951424103737,"['SMARCD1', 'SMARCD3', 'PRKAG1', 'SIRT6', 'ADCY1', 'ADCY8', 'CPT1B', 'ARID1B', 'ADCY7', 'SLC25A29', 'ADCY9', 'CPT2', 'CREB3L4', 'RPS6KA2', 'CREB3L1', 'CREB3L2', 'PPARG', 'PRKACA', 'SOS1', 'SOS2', 'MGLL', 'CREB5']",0.9967659009132112,0,0,22
77,Estrogen metabolism WP697,0.14753303973714396,2.863617747440273,5.480114246595276,"['SULT1A1', 'STS', 'ARSE']",0.9967659009132112,0,0,3
78,SARS-CoV-2 mitochondrial interactions WP5038,0.15032684963137236,1.7590027700831026,3.333210615723978,"['TOMM70', 'CTSL', 'TRAF6', 'ACAD9', 'NDUFAF1', 'ECSIT', 'NFKB1']",0.9967659009132112,0,0,7
79,Genes related to primary cilium development (based on CRISPR) WP4536,0.1577968285942268,1.3139728615596016,2.4261812067876467,"['TTC23', 'MKKS', 'DYNLT1', 'IFT140', 'ARL3', 'TUBD1', 'TXNDC15', 'TMEM231', 'IFT20', 'TMEM17', 'KIF3B', 'TCTN3', 'BBS12', 'TTC21B', 'TMEM107', 'TCTN1', 'SASS6', 'CEP83', 'IFT27', 'BBS9', 'B9D1', 'BBS4']",0.9967659009132112,0,0,22
80,IL-6 signaling pathway WP364,0.16046201277468009,1.5403970732676326,2.8184615134151367,"['NCOA1', 'GSK3B', 'MAP2K4', 'STAT1', 'PRKCD', 'GAB1', 'RAC1', 'JAK2', 'SOS1', 'VAV1']",0.9967659009132112,0,0,10
81,MAPK Signaling Pathway WP382,0.1612546260302813,1.1954450987183929,2.1814131120847366,"['PPP5D1', 'ECSIT', 'FGF1', 'STK4', 'RASGRP1', 'CDC42', 'PAK1', 'RPS6KA5', 'RAP1A', 'AKT3', 'RAC2', 'RAC1', 'PRKACA', 'MAP4K3', 'MAP3K4', 'FGF22', 'CACNG5', 'PRKCG', 'PDGFRB', 'MAP2K4', 'IL1R1', 'DUSP1', 'PRKCD', 'HSPA6', 'PLA2G4C', 'BRAF', 'TRAF2', 'FOS', 'NFKB1', 'DUSP7', 'MAPK10', 'MRAS', 'FGF14', 'TRAF6', 'RAPGEF2', 'TAB2', 'MAPT', 'PTPN7', 'SOS1', 'FGF12', 'SOS2', 'PTPN5', 'HSPA1B', 'ATF4', 'HSPA1A', 'FGF10']",0.9967659009132112,0,0,46
82,Insulin Signaling WP481,0.16126450919344995,1.2435072851245577,2.2690393672986713,"['GSK3B', 'ARF1', 'IRS1', 'RRAD', 'STXBP4', 'STXBP1', 'PTEN', 'PIK3R3', 'PIK3CD', 'PPP1R3A', 'PTPRF', 'IGF1R', 'GYS2', 'RPS6KA5', 'RPS6KA2', 'RAC2', 'RAC1', 'MAP4K5', 'MAP3K4', 'MAP4K3', 'MAP2K4', 'PRKCB', 'PRKCD', 'GAB1', 'FOS', 'MAPK10', 'EHD2', 'TBC1D4', 'PIK3CA', 'SOS1', 'SGK2', 'SOS2']",0.9967659009132112,0,0,32
83,RANKL/RANK signaling pathway WP2018,0.16132990732108451,1.469465146288152,2.6807509925444157,"['CDC42', 'NFKBIA', 'STAT1', 'TRAF6', 'TRAF5', 'TRAF2', 'TAB2', 'RAC1', 'FOS', 'TRAF1', 'SQSTM1', 'NFKB1']",0.9967659009132112,0,0,12
84,Retinoblastoma gene in cancer WP2446,0.16727377105113425,1.3435355917667238,2.4024075126185984,"['PLK4', 'RRM2', 'PRMT2', 'SUV39H1', 'HMGB2', 'HMGB1', 'ANLN', 'TFDP2', 'RBBP4', 'ORC1', 'KIF4A', 'CHEK1', 'E2F1', 'CCDC6', 'CDK1', 'MCM4', 'E2F3', 'SKP2']",0.9967659009132112,0,0,18
85,Estrogen signaling pathway WP712,0.16832850077785994,1.790186197471814,3.1898215198990925,"['PIK3CA', 'GNB1', 'BRAF', 'FOS', 'PRKACA', 'NFKB1']",0.9967659009132112,0,0,6
86,PKC-gamma calcium signaling pathway in ataxia WP4760,0.16832850077785994,1.790186197471814,3.1898215198990925,"['PRKCG', 'PLCB3', 'PLCB4', 'ATP2B2', 'CA8', 'PDK1']",0.9967659009132112,0,0,6
87,Toll-like Receptor Signaling Pathway WP75,0.17170099083724988,1.36470933934081,2.4046188662789056,"['MAP2K4', 'STAT1', 'LY96', 'PIK3R3', 'PIK3CD', 'FOS', 'NFKB1', 'NFKBIA', 'MAPK10', 'PIK3CA', 'TRAF6', 'AKT3', 'TAB2', 'RAC1', 'IFNAR1', 'NFKBIB']",0.9967659009132112,0,0,16
88,IL17 signaling pathway WP2112,0.17436398769592412,1.670933014354067,2.91846878239988,"['GSK3B', 'PIK3CA', 'TRAF6', 'IL17RE', 'JAK2', 'NFKB1', 'NFKBIB']",0.9967659009132112,0,0,7
89,Lipid Metabolism Pathway WP3965,0.17436398769592412,1.670933014354067,2.91846878239988,"['BCKDHA', 'ACSS2', 'PRKAR2B', 'AKT3', 'PRKAG1', 'PRKACA', 'ACACA']",0.9967659009132112,0,0,7
90,Resistin as a regulator of inflammation WP4481,0.17436398769592412,1.670933014354067,2.91846878239988,"['NFKBIA', 'PLCB3', 'PLCB4', 'PIK3CA', 'AKT3', 'PIK3CD', 'NFKB1']",0.9967659009132112,0,0,7
91,G13 Signaling Pathway WP524,0.1793841060106449,1.5347005081102207,2.6369622055794495,"['CDC42', 'GNA13', 'MAPK10', 'CYFIP1', 'PIK3CA', 'PIK3CD', 'RAC1', 'MAP3K4', 'RHOA']",0.9967659009132112,0,0,9
92,ATR Signaling WP3875,0.19406617210295535,2.3861774744027304,3.9122717974830885,"['CHEK1', 'RAD1', 'ATRIP']",0.9967659009132112,0,0,3
93,Biotin Metabolism (including IEMs) WP5031,0.19406617210295535,2.3861774744027304,3.9122717974830885,"['PCCB', 'ACACB', 'ACACA']",0.9967659009132112,0,0,3
94,PTF1A related regulatory pathway WP4147,0.19406617210295535,2.3861774744027304,3.9122717974830885,"['KAT2B', 'PROX1', 'FGF10']",0.9967659009132112,0,0,3
95,Serotonin Transporter Activity WP1455,0.19406617210295535,2.3861774744027304,3.9122717974830885,"['PPP2CB', 'IL1R1', 'STX1A']",0.9967659009132112,0,0,3
96,Supression of HMGB1 mediated inflammation by THBD WP4479,0.19406617210295535,2.3861774744027304,3.9122717974830885,"['NFKBIA', 'HMGB1', 'NFKB1']",0.9967659009132112,0,0,3
97,AGE/RAGE pathway WP2324,0.194451899062329,1.3795433789954339,2.2590994748342808,"['IRS1', 'PRKCB', 'STAT1', 'PRKCD', 'DDOST', 'RHOA', 'NFKB1', 'CASP9', 'CDC42', 'NFKBIA', 'ALPL', 'RAC1', 'JAK2']",0.9967659009132112,0,0,13
98,EPO Receptor Signaling WP581,0.19641013774445795,1.684760545830905,2.7420324754407783,"['PTPRU', 'IRS1', 'STAT1', 'JAK2', 'SOS1', 'PDK1']",0.9967659009132112,0,0,6
99,IL-4 signaling pathway WP395,0.1987228212546971,1.4195386351443846,2.293753388383348,"['NFKBIA', 'PIK3CA', 'IRS1', 'STAT1', 'INPP5D', 'PIK3CD', 'FOS', 'JAK2', 'SOS1', 'JAK3', 'NFKB1']",0.9967659009132112,0,0,11
100,Rett syndrome causing genes WP4312,0.1987228212546971,1.4195386351443846,2.293753388383348,"['SYNGAP1', 'TRRAP', 'SATB2', 'STXBP1', 'SCN8A', 'GABRA3', 'BRAF', 'TCF4', 'SMARCA1', 'RHOBTB2', 'SCN1A']",0.9967659009132112,0,0,11
101,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.19991654781869317,1.5912508544087491,2.5616835586148645,"['ITGB1', 'LAMA5', 'EDA', 'CCND2', 'FGF1', 'NFKB1', 'GTPBP4']",0.9967659009132112,0,0,7
102,Apoptosis WP254,0.20553760378419436,1.32653644048435,2.0987481572372357,"['HRK', 'HELLS', 'MAP2K4', 'CRADD', 'TRAF2', 'TRAF1', 'NFKB1', 'IGF1R', 'CASP9', 'NFKBIA', 'MAPK10', 'CASP6', 'CASP2', 'BCL2L2', 'NFKBIB']",0.9967659009132112,0,0,15
103,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.2089766645622446,1.337074340527578,2.0932335837923106,"['STAT1', 'PDE4D', 'KCNIP3', 'BRAF', 'TTF2', 'FOS', 'TTF1', 'IGF1R', 'GNA13', 'RAP1A', 'PIK3CA', 'GNB1', 'E2F1', 'JAK2']",0.9967659009132112,0,0,14
104,Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension) WP4661,0.20916931852083867,3.181166837256909,4.977289321611296,"['UROC1', 'FTCD']",0.9967659009132112,0,0,2
105,Composition of Lipid Particles WP3601,0.20916931852083867,3.181166837256909,4.977289321611296,"['APOA1', 'LPL']",0.9967659009132112,0,0,2
106,Mitochondrial fatty acid synthesis pathway WP4317,0.20916931852083867,3.181166837256909,4.977289321611296,"['MECR', 'ACACA']",0.9967659009132112,0,0,2
107,FOXA2 pathway WP5066,0.2139671486354145,1.909047456469785,2.943622864676029,"['ABCC4', 'IRS1', 'ACACA', 'SLC27A5']",0.9967659009132112,0,0,4
108,Corticotropin-releasing hormone signaling pathway WP2355,0.21399188439200725,1.2886863936246653,1.9869188317369242,"['GSK3B', 'NCOA2', 'HSP90AA1', 'PARP1', 'PRKCB', 'PRKCD', 'CAMK2A', 'BRAF', 'FOS', 'RHOA', 'ACACA', 'NFKB1', 'CASP9', 'NFKBIA', 'GNB1', 'TCF4', 'GNB5']",0.9967659009132112,0,0,17
109,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.21876890644537392,1.3820832883028928,2.100406327825727,"['NFKBIA', 'GSK3B', 'ITK', 'ZAP70', 'PAK1', 'DLG1', 'PIK3CA', 'FOS', 'SOS1', 'NFKB1', 'PDK1']",0.9967659009132112,0,0,11
110,Nucleotide Excision Repair WP4753,0.2216324148327714,1.4041778189209313,2.1157239481154155,"['DDB1', 'CDK7', 'ERCC3', 'RFC2', 'CETN2', 'POLD1', 'ERCC2', 'ERCC8', 'GTF2H3', 'RBX1']",0.9967659009132112,0,0,10
111,Ebstein-Barr virus LMP1 signaling WP262,0.22260380025545995,1.7046008977361435,2.560927218729085,"['NFKBIA', 'HSP90AA1', 'TRAF6', 'TRAF1', 'NFKB1']",0.9967659009132112,0,0,5
112,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.22260380025545995,1.7046008977361435,2.560927218729085,"['PRKAG1', 'PDHB', 'ACACB', 'ACACA', 'PDK1']",0.9967659009132112,0,0,5
113,RAS and bradykinin pathways in COVID-19 WP4969,0.22260380025545995,1.7046008977361435,2.560927218729085,"['CYP24A1', 'REN', 'KLKB1', 'NFKB1', 'RHOA']",0.9967659009132112,0,0,5
114,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.22663474968870304,1.3107631541825364,1.945717260330919,"['HSPA9', 'PSMD13', 'SIAH2', 'HSPA6', 'UBE2G2', 'UBE2J2', 'HSPA14', 'TUBB8', 'TUBB2A', 'PSMD4', 'RNF19A', 'PSMC1', 'HSPA1B', 'HSPA1A']",0.9967659009132112,0,0,14
115,G Protein Signaling Pathways WP35,0.24086204553514276,1.2457304795286748,1.7733358737267277,"['PRKCG', 'PRKCB', 'PDE4D', 'PRKCD', 'AKAP5', 'ADCY1', 'ADCY8', 'ADCY7', 'AKAP3', 'RHOA', 'GNA13', 'PLCB3', 'ADCY9', 'PRKAR2B', 'GNB1', 'PDE4B', 'GNB5', 'PRKACA']",0.9967659009132112,0,0,18
116,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.24315225211697167,1.1312086675109048,1.5996053897326168,"['ITGB1', 'GSK3B', 'HSP90AB1', 'IRS1', 'TNC', 'PTEN', 'PIK3CD', 'ITGAE', 'LAMC1', 'FGF1', 'IGF1R', 'GYS2', 'CASP9', 'CREB3L4', 'CREB3L1', 'CREB3L2', 'AKT3', 'ITGB8', 'ITGAV', 'JAK2', 'JAK3', 'RAB8A', 'PDGFRB', 'RAB2A', 'HSP90AA1', 'PPP2R5A', 'TBC1D1', 'PIK3CA', 'ITGA8', 'EIF4E2', 'SOS1', 'ATF4', 'IFNAR1', 'CREB5', 'LAMA5', 'LAMA1', 'LPAR2', 'EFNA5', 'ACACA', 'PPP2CB', 'FGF22', 'VEGFC', 'EFNA2', 'FGF14', 'COL5A1', 'ITGA10', 'GNB1', 'FGF12', 'FGF10']",0.9967659009132112,0,0,49
117,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.2516378575481375,1.414320987654321,1.9514296050628646,"['CREB3L4', 'CREB3L1', 'CAMK2A', 'CREB3L2', 'ITPR2', 'REN', 'CREB5', 'ATF4']",0.9967659009132112,0,0,8
118,Base Excision Repair WP4752,0.254836326418501,1.4526731849386312,1.9859986072480835,"['PARP1', 'MPG', 'POLD1', 'APEX2', 'POLL', 'LIG3', 'HMGB1']",0.9967659009132112,0,0,7
119,Genes controlling nephrogenesis WP4823,0.254836326418501,1.4526731849386312,1.9859986072480835,"['RET', 'ITGB1', 'PDGFRB', 'NPHS1', 'ITGA8', 'ETV4', 'CD2AP']",0.9967659009132112,0,0,7
120,Striated Muscle Contraction Pathway WP383,0.2570603854630681,1.5072015535935843,2.0474492973261977,"['MYOM1', 'ACTA1', 'TPM4', 'TPM3', 'TNNC2', 'TPM1']",0.9967659009132112,0,0,6
121,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.25750539487174606,1.590846994535519,2.158325356801281,"['B3GALNT1', 'SGPL1', 'GALNT16', 'SGMS2', 'ST6GALNAC3']",0.9967659009132112,0,0,5
122,"Relationship between inflammation, COX-2 and EGFR WP4483",0.25750539487174606,1.590846994535519,2.158325356801281,"['PIK3CA', 'AKT3', 'PIK3CD', 'BRAF', 'PTGS2']",0.9967659009132112,0,0,5
123,Pathogenic Escherichia coli infection WP2272,0.26111583941705147,1.3127908966461328,1.7628039859209768,"['ITGB1', 'TUBB8', 'CDC42', 'TUBB2A', 'ARPC2', 'ARPC3', 'LY96', 'ARPC4', 'ARHGEF2', 'YWHAZ', 'RHOA']",0.9967659009132112,0,0,11
124,Endometrial cancer WP4155,0.26993932521322167,1.2665641599105395,1.6586393125658565,"['GSK3B', 'PTEN', 'PIK3CD', 'PIK3R3', 'BRAF', 'FOS', 'FGF1', 'CASP9', 'PIK3CA', 'AKT3', 'ERBB2', 'SOS1', 'SOS2']",0.9967659009132112,0,0,13
125,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.27247585453290835,1.3424781976744187,1.7454972355626301,"['ITGB1', 'MAPK10', 'ACTA1', 'PAK1', 'ITGB8', 'NF2', 'MAP4K5', 'TEAD1', 'MAP4K3']",0.9967659009132112,0,0,9
126,Leptin signaling pathway WP2034,0.2760318084215943,1.2346966509891044,1.5893498946918563,"['NCOA1', 'GSK3B', 'IRS1', 'STAT1', 'PTEN', 'ACACB', 'RHOA', 'ACACA', 'NFKB1', 'CDC42', 'ERBB2', 'RAC1', 'JAK2', 'SOS1', 'SH2B1']",0.9967659009132112,0,0,15
127,Notch Signaling Pathway Netpath WP61,0.2764580299559482,1.2729887024991442,1.636676813743264,"['DLL4', 'GSK3B', 'NUMBL', 'NCSTN', 'MAML2', 'HEY1', 'PSEN2', 'CIR1', 'MAPT', 'JAK2', 'DLL1', 'NFKB1']",0.9967659009132112,0,0,12
128,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.27819676853770464,1.3637118437118436,1.7447692282658402,"['ITGB1', 'GSK3B', 'IRS1', 'PTEN', 'RICTOR', 'NFKB1', 'IGF1R', 'PDK1']",0.9967659009132112,0,0,8
129,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.27819676853770464,1.3637118437118436,1.7447692282658402,"['GABRQ', 'GABRB1', 'PIK3CA', 'GABRA3', 'PTEN', 'PIK3R3', 'JAK2', 'RHOA']",0.9967659009132112,0,0,8
130,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.2793278980365367,2.3857045377004433,3.0426534327134105,"['GGCT', 'GSS']",0.9967659009132112,0,0,2
131,Metastatic brain tumor WP2249,0.2793278980365367,2.3857045377004433,3.0426534327134105,"['CDC42', 'E2F3']",0.9967659009132112,0,0,2
132,"Phase I biotransformations, non P450 WP136",0.2793278980365367,2.3857045377004433,3.0426534327134105,"['ESD', 'CES2']",0.9967659009132112,0,0,2
133,Pilocytic astrocytoma WP2253,0.2793278980365367,2.3857045377004433,3.0426534327134105,"['BRAF', 'SOS1']",0.9967659009132112,0,0,2
134,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.2793278980365367,2.3857045377004433,3.0426534327134105,"['PTEN', 'IGF1R']",0.9967659009132112,0,0,2
135,16p11.2 distal deletion syndrome WP4950,0.2890804434032422,1.4317389818927229,1.7768600625406314,"['CD81', 'TRAF2', 'TRAF1', 'JAK2', 'RAB5A', 'SH2B1']",0.9967659009132112,0,0,6
136,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.2890804434032422,1.4317389818927229,1.7768600625406314,"['TTC9', 'PNCK', 'TPM3', 'ERBB2', 'NR3C1', 'JAK2']",0.9967659009132112,0,0,6
137,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.29033672859819876,1.2900481733872087,1.5954205031798794,"['NFKBIA', 'MAPK10', 'MAP2K4', 'RPS6KA5', 'IL1R1', 'TRAF6', 'TAB2', 'FOS', 'NFKB1', 'NFKBIB']",0.9967659009132112,0,0,10
138,Pregnane X receptor pathway WP2876,0.29357471555220893,1.4913123292349726,1.8277868469472487,"['NCOA1', 'NCOA2', 'ABCC4', 'HSP90AA1', 'DNAJC7']",0.9967659009132112,0,0,5
139,"NAD metabolism, sirtuins and aging WP3630",0.29464752198589683,1.7893771331058022,2.186574977118678,"['PARP1', 'PPARG', 'NFKB1']",0.9967659009132112,0,0,3
140,NOTCH1 regulation of endothelial cell calcification WP3413,0.29629727276440543,1.590645271423694,1.9348482287287494,"['DLL4', 'CALU', 'ALPL', 'DLL1']",0.9967659009132112,0,0,4
141,Transcription co-factors SKI and SKIL protein partners WP4533,0.29629727276440543,1.590645271423694,1.9348482287287494,"['PRMT5', 'ING2', 'SATB2', 'TEAD1']",0.9967659009132112,0,0,4
142,Oxidative Damage WP3941,0.30545543074474096,1.3165929855585028,1.5614152951852913,"['CDC42', 'CASP9', 'MAPK10', 'MAP2K4', 'TRAF6', 'TRAF2', 'TRAF1', 'NFKB1']",0.9967659009132112,0,0,8
143,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.30545543074474096,1.3165929855585028,1.5614152951852913,"['NFKBIA', 'GSK3B', 'TRAF5', 'TRAF2', 'RAC1', 'TRAF1', 'NFKB1', 'NFKBIB']",0.9967659009132112,0,0,8
144,Vitamin D-sensitive calcium signaling in depression WP4698,0.30545543074474096,1.3165929855585028,1.5614152951852913,"['KDM6B', 'GRM5', 'G6PD', 'CALB1', 'ITPR2', 'ATP2B3', 'ATP2B2', 'SLC8A1']",0.9967659009132112,0,0,8
145,IL-1 signaling pathway WP195,0.3059093945726573,1.2500977803852547,1.480698713876137,"['NFKBIA', 'MAP2K4', 'IL1R1', 'TRAF6', 'PELI2', 'TAB2', 'UBE2V1', 'ECSIT', 'SQSTM1', 'NFKB1', 'NFKBIB']",0.9967659009132112,0,0,11
146,Melanoma WP4685,0.3109219196058495,1.2167203867848508,1.4213891337318565,"['PTEN', 'PIK3CD', 'PIK3R3', 'BRAF', 'FOS', 'PAK1', 'PIK3CA', 'AKT3', 'E2F1', 'E2F3', 'RAC1', 'SOS1', 'SOS2']",0.9967659009132112,0,0,13
147,Fatty acid beta-oxidation WP143,0.3135050170583849,1.336267942583732,1.5499905246213204,"['ECHS1', 'ACSS2', 'CPT2', 'LPL', 'CPT1B', 'DLD', 'DECR1']",0.9967659009132112,0,0,7
148,Pathways Regulating Hippo Signaling WP4540,0.31583413808547744,1.176119759050516,1.355522812085225,"['PDGFRB', 'PRKCG', 'PRKCB', 'PRKCD', 'PRKAG1', 'CDH8', 'RHOA', 'IGF1R', 'CDC42', 'PLCB3', 'PLCB4', 'PRKAR2B', 'NF2', 'RAC1', 'PRKACA', 'TEAD1', 'CDH18']",0.9967659009132112,0,0,17
149,Arylamine metabolism WP694,0.31661597072329706,4.770804911323329,5.486739034203308,['SULT1A1'],0.9967659009132112,0,0,1
150,SCFA and skeletal muscle substrate metabolism WP4030,0.31661597072329706,4.770804911323329,5.486739034203308,['PYY'],0.9967659009132112,0,0,1
151,7q11.23 copy number variation syndrome WP4932,0.31679805902730845,1.1628609893881,1.3366979460329618,"['BECN1', 'RFC2', 'ELN', 'EIF2AK3', 'VPS37C', 'DDX21', 'NRG1', 'ACACB', 'ACACA', 'GRIP1', 'CLIP2', 'MYBBP1A', 'METTL27', 'SQSTM1', 'DLD', 'STX1A', 'ATF4', 'FBN1', 'ATPAF1']",0.9967659009132112,0,0,19
152,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.31967800343820313,1.218644154217078,1.3897917932720343,"['PRKCG', 'RXRB', 'PLCB3', 'PLCB4', 'CYP24A1', 'PRKCB', 'STAT1', 'PRKCD', 'CAMK2A', 'SP3', 'ISG15', 'NFKB1']",0.9967659009132112,0,0,12
153,Oncostatin M Signaling Pathway WP2374,0.31967800343820313,1.218644154217078,1.3897917932720343,"['NFKBIA', 'IRS1', 'PRKCB', 'STAT1', 'PRKCD', 'PXN', 'RICTOR', 'FOS', 'JAK2', 'SOS1', 'JAK3', 'NFKB1']",0.9967659009132112,0,0,12
154,Proteasome Degradation WP183,0.31967800343820313,1.218644154217078,1.3897917932720343,"['PSMA5', 'PSMB7', 'PSMA3', 'PSMD4', 'PSMA1', 'PSMB2', 'UBE2B', 'PSMD13', 'PSMB3', 'UBE2D2', 'PSMC1', 'PSME2']",0.9967659009132112,0,0,12
155,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.321856568671986,1.36346332178242,1.545689201567394,"['MTMR2', 'EGR2', 'RAB4B', 'HSPB8', 'MPZ', 'NDRG1']",0.9967659009132112,0,0,6
156,Nanoparticle-mediated activation of receptor signaling WP2643,0.321856568671986,1.36346332178242,1.545689201567394,"['ITGB1', 'MAPK10', 'PXN', 'AKT3', 'PIK3CD', 'SOS1']",0.9967659009132112,0,0,6
157,Oxidative Stress WP408,0.321856568671986,1.36346332178242,1.545689201567394,"['MAPK10', 'GPX3', 'CAT', 'NOX4', 'FOS', 'NFKB1']",0.9967659009132112,0,0,6
158,Type II interferon signaling (IFNG) WP619,0.321856568671986,1.36346332178242,1.545689201567394,"['STAT1', 'IFNGR2', 'PRKCD', 'IFI6', 'ISG15', 'JAK2']",0.9967659009132112,0,0,6
159,Myometrial relaxation and contraction pathways WP289,0.3234911198751199,1.1284798448885136,1.2735838634445584,"['RYR2', 'CAMK2A', 'ITPR2', 'ADCY1', 'ADCY8', 'ADCY7', 'SLC8A1', 'RGS3', 'PRKAR2B', 'PDE4B', 'PRKACA', 'PRKCG', 'PRKCB', 'PDE4D', 'IGFBP2', 'PRKCD', 'FOS', 'YWHAZ', 'NFKB1', 'ACTA1', 'PLCB3', 'ADCY9', 'GNB1', 'GNB5', 'ATF5', 'ATF4']",0.9967659009132112,0,0,26
160,Glioblastoma signaling pathways WP2261,0.3244233347073495,1.174990111020279,1.3226934501473113,"['PRKCG', 'PDGFRB', 'MAP2K4', 'IRS1', 'PRKCB', 'PRKCD', 'PTEN', 'GAB1', 'PIK3CD', 'BRAF', 'IGF1R', 'CCND2', 'PIK3CA', 'AKT3', 'ERBB2', 'E2F1']",0.9967659009132112,0,0,16
161,Regulation of toll-like receptor signaling pathway WP1449,0.325343053984895,1.1503066850305443,1.2916507370114798,"['OTUD5', 'MAP2K4', 'STAT1', 'PELI2', 'TRAFD1', 'LY96', 'PIK3R3', 'PIK3CD', 'FOS', 'NFKB1', 'NFKBIA', 'MAPK10', 'PIK3CA', 'TRAF6', 'AKT3', 'TAB2', 'RAC1', 'ZMYND11', 'SQSTM1', 'IFNAR1']",0.9967659009132112,0,0,20
162,Constitutive Androstane Receptor Pathway WP2875,0.3304118314542819,1.40348762455802,1.5542438491305188,"['SULT1A1', 'NCOA1', 'NCOA2', 'HSP90AA1', 'DNAJC7']",0.9967659009132112,0,0,5
163,NRF2-ARE regulation WP4357,0.3304118314542819,1.40348762455802,1.5542438491305188,"['GSK3B', 'AIMP2', 'MAF', 'PIK3CA', 'RBX1']",0.9967659009132112,0,0,5
164,Unfolded protein response WP4925,0.3304118314542819,1.40348762455802,1.5542438491305188,"['RTCB', 'EIF2AK3', 'CASP2', 'EIF2S1', 'ATF4']",0.9967659009132112,0,0,5
165,NRF2 pathway WP2884,0.33337853094993747,1.139177229020979,1.2513596489575887,"['CBR1', 'ABCC4', 'G6PD', 'HSP90AA1', 'HSP90AB1', 'GPX3', 'MGST3', 'TGFA', 'SLC39A10', 'NRG1', 'CES4A', 'DNAJB1', 'GSTA4', 'SLC39A9', 'SLC39A7', 'SLC39A1', 'SQSTM1', 'SLC39A4', 'CES2', 'SLC39A3', 'HSPA1A']",0.9967659009132112,0,0,21
166,Apoptosis Modulation and Signaling WP1772,0.3334975564905265,1.1737210530455398,1.2888862582112202,"['HRK', 'TNFRSF6B', 'CRADD', 'IL1R1', 'FOS', 'NFKB1', 'CASP9', 'NFKBIA', 'CAPNS1', 'CASP6', 'TRAF6', 'CASP2', 'BIRC6', 'BCL2L2', 'HSPA1A']",0.9967659009132112,0,0,15
167,Copper homeostasis WP3286,0.3389781419977429,1.2237164135898313,1.323840464161968,"['BACE1', 'GSK3B', 'CCS', 'ATP7B', 'SCO1', 'PIK3CA', 'PTEN', 'ADAM10', 'COX11', 'MAPT']",0.9967659009132112,0,0,10
168,Amyotrophic lateral sclerosis (ALS) WP2447,0.34372563023828284,1.284781008465219,1.3720324477970556,"['CASP9', 'CCS', 'TOMM40', 'ALS2', 'CAT', 'RAC1', 'RAB5A']",0.9967659009132112,0,0,7
169,Nuclear receptors WP170,0.34372563023828284,1.284781008465219,1.3720324477970556,"['RXRB', 'THRA', 'RORA', 'ROR1', 'PPARG', 'NR2C2', 'NR3C1']",0.9967659009132112,0,0,7
170,Cancer immunotherapy by CTLA4 blockade WP4582,0.3462998714203102,1.5904436860068258,1.6865863231166753,"['PIK3CA', 'PIK3CD', 'PIK3R3']",0.9967659009132112,0,0,3
171,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.3462998714203102,1.5904436860068258,1.6865863231166753,"['NFKBIA', 'TRAF6', 'NFKB1']",0.9967659009132112,0,0,3
172,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.3462998714203102,1.5904436860068258,1.6865863231166753,"['LPL', 'APOA1', 'LDLRAP1']",0.9967659009132112,0,0,3
173,RalA downstream regulated genes WP2290,0.3462998714203102,1.5904436860068258,1.6865863231166753,"['CDC42', 'RAC2', 'RAC1']",0.9967659009132112,0,0,3
174,"Cerebral organic acidurias, including diseases WP4519",0.3489307216270643,1.9084271579665644,2.009348377455556,"['MDH2', 'IDH2']",0.9967659009132112,0,0,2
175,Insulin signaling in adipocytes (diabetic condition) WP3635,0.3489307216270643,1.9084271579665644,2.009348377455556,"['TBC1D4', 'IRS1']",0.9967659009132112,0,0,2
176,Insulin signaling in adipocytes (normal condition) WP3634,0.3489307216270643,1.9084271579665644,2.009348377455556,"['TBC1D4', 'IRS1']",0.9967659009132112,0,0,2
177,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.3489307216270643,1.9084271579665644,2.009348377455556,"['NFKBIA', 'NFKB1']",0.9967659009132112,0,0,2
178,ATM Signaling Network in Development and Disease  WP3878,0.34973175314652855,1.2271448114129373,1.2892246413937334,"['MDC1', 'G6PD', 'CHEK1', 'RNF8', 'CDK1', 'PPM1D', 'BUB1', 'NFKB1', 'HMGN1']",0.9967659009132112,0,0,9
179,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.34973175314652855,1.2271448114129373,1.2892246413937334,"['ADCY9', 'TMEM43', 'ADCY1', 'SYNE4', 'ADCY8', 'SOS1', 'ADCY7', 'SOS2', 'RHOA']",0.9967659009132112,0,0,9
180,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.3551129310380227,1.3013945398639626,1.347359046052498,"['ADAMTS2', 'CRTAP', 'CREB3L1', 'SERPINH1', 'PLOD2', 'P4HB']",0.9967659009132112,0,0,6
181,EGF/EGFR signaling pathway WP437,0.35631790220808796,1.0987226157680703,1.1338069855417237,"['STXBP1', 'CAMK2A', 'PTEN', 'PEBP1', 'CDC42', 'PAK1', 'RPS6KA5', 'RAP1A', 'RPS6KA2', 'INPP5D', 'ERBB2', 'E2F1', 'RICTOR', 'RAC1', 'JAK2', 'MAP3K4', 'VAV3', 'PRKCB', 'STAT1', 'PRKCD', 'GAB1', 'BRAF', 'FOS', 'VAV1', 'STAMBP', 'SOS1', 'RAB5A', 'SOS2', 'PTPN5']",0.9967659009132112,0,0,29
182,Ciliopathies WP4803,0.35915581422702214,1.0911705323287537,1.1173574921838139,"['ARL3', 'TCTN3', 'CSPP1', 'TTC21B', 'TMEM107', 'TCTN1', 'NEK1', 'BBS9', 'BBS4', 'CEP78', 'PLK4', 'DNAH11', 'MKKS', 'IFT140', 'DCDC2', 'CFAP410', 'POMGNT1', 'TMEM231', 'RSPH3', 'AHI1', 'CENPF', 'RSPH1', 'TMEM17', 'TMEM138', 'BBS12', 'SPAG1', 'CEP83', 'IFT27', 'HYLS1', 'B9D1', 'CEP41', 'CCNO']",0.9967659009132112,0,0,32
183,G1 to S cell cycle control WP45,0.3643160037127066,1.168735895590691,1.1801119569430183,"['PRIM2', 'CDK7', 'CCND2', 'ORC6', 'TFDP2', 'ORC1', 'CREB3L4', 'CREB3L1', 'E2F1', 'CDK1', 'MCM4', 'E2F3']",0.9967659009132112,0,0,12
184,TLR4 Signaling and Tolerance WP3851,0.36763451544751424,1.3254212204007285,1.3263039494393667,"['NFKBIA', 'INPP5D', 'TRAF6', 'TAB2', 'NFKB1']",0.9967659009132112,0,0,5
185,Microglia Pathogen Phagocytosis Pathway WP3937,0.37426276354479215,1.2371079213184477,1.2158261417090337,"['VAV3', 'PIK3CA', 'RAC2', 'PIK3R3', 'PIK3CD', 'RAC1', 'VAV1']",0.9967659009132112,0,0,7
186,p38 MAPK Signaling Pathway WP400,0.37426276354479215,1.2371079213184477,1.2158261417090337,"['CDC42', 'MAP2K4', 'RPS6KA5', 'STAT1', 'TRAF2', 'RAC1', 'HMGN1']",0.9967659009132112,0,0,7
187,Breast cancer pathway WP4262,0.37663800713716467,1.094733919715306,1.068975647349079,"['GSK3B', 'PTEN', 'PIK3R3', 'PIK3CD', 'FGF1', 'DLL1', 'IGF1R', 'DLL4', 'HEY1', 'AKT3', 'ERBB2', 'E2F1', 'E2F3', 'FGF22', 'NCOA1', 'WNT10B', 'WNT10A', 'CSNK2A1', 'PARP1', 'BRAF', 'FOS', 'PIK3CA', 'SOS1', 'SOS2', 'FGF10']",0.9967659009132112,0,0,25
188,Spinal Cord Injury WP2431,0.3790935480381216,1.1156623822146978,1.0821615798568924,"['EPHA4', 'IL1R1', 'NCAN', 'FOS', 'PDYN', 'PLA2G6', 'PTGS2', 'RHOA', 'RHOB', 'CDC42', 'ACAN', 'GAP43', 'CDK1', 'E2F1', 'NOX4', 'RAC1', 'LTB', 'E2F5']",0.9967659009132112,0,0,18
189,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.3885844633023502,1.2447230433297187,1.1765678896066887,"['GSK3B', 'PIK3CA', 'PTEN', 'PIK3R3', 'RICTOR', 'PDK1']",0.9967659009132112,0,0,6
190,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.388875170421011,1.1638560449921982,1.0992584096926246,"['NFKBIA', 'MAPK10', 'OTUD5', 'IFNE', 'TRAF6', 'DHX58', 'TRAF2', 'ISG15', 'NFKB1', 'NFKBIB']",0.9967659009132112,0,0,10
191,Phosphodiesterases in neuronal function WP4222,0.388875170421011,1.1638560449921982,1.0992584096926246,"['PDE11A', 'ADCY9', 'PDE10A', 'PDE6H', 'PDE4D', 'PDE4B', 'ADCY1', 'DRD1', 'ADCY8', 'ADCY7']",0.9967659009132112,0,0,10
192,Cori Cycle WP1946,0.3975429130232472,1.431296928327645,1.3203032772355852,"['G6PD', 'TALDO1', 'PFKP']",0.9967659009132112,0,0,3
193,Development and heterogeneity of the ILC family WP3893,0.3975429130232472,1.431296928327645,1.3203032772355852,"['IL15', 'ZBTB16', 'RORA']",0.9967659009132112,0,0,3
194,Ganglio Sphingolipid Metabolism WP1423,0.3975429130232472,1.431296928327645,1.3203032772355852,"['ST8SIA1', 'B3GALT4', 'ST3GAL5']",0.9967659009132112,0,0,3
195,Glutathione metabolism WP100,0.3975429130232472,1.431296928327645,1.3203032772355852,"['G6PD', 'GPX3', 'GSS']",0.9967659009132112,0,0,3
196,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.3975429130232472,1.431296928327645,1.3203032772355852,"['CDK8', 'H2AFY', 'E2F1']",0.9967659009132112,0,0,3
197,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.3975429130232472,1.431296928327645,1.3203032772355852,"['TRAF6', 'UBE2V1', 'NFKB1']",0.9967659009132112,0,0,3
198,miRNAs involvement in the immune response in sepsis WP4329,0.40488641427759836,1.2555723324705206,1.1352241044453282,"['NFKBIA', 'TRAF6', 'TAB2', 'ELANE', 'NFKB1']",0.9967659009132112,0,0,5
199,Pathways affected in adenoid cystic carcinoma WP3651,0.4097315973709875,1.1227420101899028,1.0017698978658718,"['KDM6B', 'PIK3CA', 'KAT6A', 'MYB', 'CHEK1', 'ATRX', 'ERBB2', 'PTEN', 'ERBIN', 'ARID5B', 'ARID4B', 'DTX4']",0.9967659009132112,0,0,12
200,Nuclear Receptors Meta-Pathway WP2882,0.411723770393735,1.0500449982692974,0.9318126770178287,"['HSP90AB1', 'MGST3', 'ABCB4', 'TGFA', 'ABCB11', 'PTGS2', 'NR3C1', 'SULT1A1', 'DNAJB1', 'GPR153', 'CPT2', 'SLC39A9', 'PDE4B', 'SLC39A7', 'SLC39A1', 'SLC39A4', 'CAP2', 'SLC39A3', 'NCOA1', 'IL11', 'CBR1', 'NCOA2', 'ABCC4', 'G6PD', 'HSP90AA1', 'GPX3', 'PTGES3', 'MYOF', 'SLC39A10', 'APOA1', 'SERPINB9', 'NRG1', 'SMARCA1', 'CES4A', 'TGFBR3', 'KAT2B', 'GSTA4', 'DNAJC7', 'CDK1', 'SQSTM1', 'CES2', 'SLC27A5', 'HSPA1A', 'FKBP5']",0.9967659009132112,0,0,44
201,Canonical NF-KB pathway WP4562,0.41606325937400673,1.5902422381439782,1.3945119865014368,"['NFKBIA', 'NFKB1']",0.9967659009132112,0,0,2
202,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.41606325937400673,1.5902422381439782,1.3945119865014368,"['CUL2', 'RBX1']",0.9967659009132112,0,0,2
203,Macrophage markers WP4146,0.41606325937400673,1.5902422381439782,1.3945119865014368,"['RAC2', 'CD68']",0.9967659009132112,0,0,2
204,Vitamin D Metabolism WP1531,0.41606325937400673,1.5902422381439782,1.3945119865014368,"['RXRB', 'CYP24A1']",0.9967659009132112,0,0,2
205,Hepatitis C and Hepatocellular Carcinoma WP3646,0.4182453647670221,1.1566744366744366,1.0082580946915847,"['CASP9', 'RRM2', 'PODXL', 'MYOF', 'RAC1', 'SOS1', 'PTGS2', 'NFKB1']",0.9967659009132112,0,0,8
206,Splicing factor NOVA regulated synaptic proteins WP4148,0.4182453647670221,1.1566744366744366,1.0082580946915847,"['NTNG1', 'PLCB4', 'CADM1', 'EPB41', 'CLSTN1', 'GRIK2', 'EFNA5', 'NEO1']",0.9967659009132112,0,0,8
207,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4220214867870226,1.1927741715066622,1.0290051442480919,"['RAP1A', 'LPL', 'RAC1', 'NDRG1', 'TEAD1', 'RHOA']",0.9967659009132112,0,0,6
208,Hippo-Merlin Signaling Dysregulation WP4541,0.422180344614492,1.0793337582115894,0.9307339998597673,"['PDGFRB', 'ITGB1', 'ITGAE', 'CDH8', 'IGF1R', 'RBX1', 'DCAF1', 'DDB1', 'PAK1', 'PLCB4', 'PRKAR2B', 'ITGA10', 'ITGA8', 'ITGB8', 'ITGAV', 'NF2', 'PRKACA', 'TEAD1', 'CDH18']",0.9967659009132112,0,0,19
209,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.4240179440327188,1.2722430863776033,1.091558491980789,"['RPS6KA5', 'RAP1A', 'BRAF', 'NR3C1']",0.9967659009132112,0,0,4
210,Exercise-induced Circadian Regulation WP410,0.42947428381145725,1.1300219598243213,0.9550871181887026,"['HIST1H2BN', 'DAZAP2', 'PPP2CB', 'CBX3', 'CRY2', 'TAB2', 'CLOCK', 'AZIN1', 'EIF4G2']",0.9967659009132112,0,0,9
211,GABA metabolism (aka GHB) WP4157,0.43507711264291205,2.385231923601637,1.9850663179291046,['AKR7A2'],0.9967659009132112,0,0,1
212,Cannabinoid receptor signaling WP3869,0.4418429081017107,1.1927083333333333,0.9742052062463716,"['MAPK10', 'PRKAR2B', 'ADCY1', 'PRKACA', 'ADCY7']",0.9967659009132112,0,0,5
213,Eukaryotic Transcription Initiation WP405,0.4466010698469875,1.1225741578682755,0.9048952910689024,"['CDK7', 'TAF12', 'ERCC3', 'POLR3D', 'ERCC2', 'POLR2F', 'POLR1E', 'GTF2H3']",0.9967659009132112,0,0,8
214,Cysteine and methionine catabolism WP4504,0.4476090108621257,1.3010859447719516,1.0458586432149073,"['BHMT', 'GSS', 'SUOX']",0.9967659009132112,0,0,3
215,Galanin receptor pathway WP4970,0.4476090108621257,1.3010859447719516,1.0458586432149073,"['PRKCD', 'PPARG', 'FOS']",0.9967659009132112,0,0,3
216,Leptin Insulin Overlap WP3935,0.4476090108621257,1.3010859447719516,1.0458586432149073,"['IRS1', 'PIK3R3', 'JAK2']",0.9967659009132112,0,0,3
217,Phytochemical activity on NRF2 transcriptional activation WP3,0.4476090108621257,1.3010859447719516,1.0458586432149073,"['AIMP2', 'MAF', 'PIK3CA']",0.9967659009132112,0,0,3
218,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.45519326261891324,1.14498120942945,0.9011382219964605,"['NFKBIA', 'STAT1', 'TRAF6', 'FOS', 'NFKB1', 'IFNAR1']",0.9967659009132112,0,0,6
219,Cytosolic DNA-sensing pathway WP4655,0.45601934418932843,1.1009681153320003,0.8645022373579934,"['NFKBIA', 'POLR3A', 'POLR3GL', 'POLR3D', 'POLR3F', 'POLR2F', 'ISG15', 'NFKB1', 'NFKBIB']",0.9967659009132112,0,0,9
220,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.4656460640764837,1.1926425401160805,0.9115718198182583,"['TRAF6', 'PTGS2', 'NFKB1', 'BCL2L2']",0.9967659009132112,0,0,4
221,Triacylglyceride synthesis WP325,0.4656460640764837,1.1926425401160805,0.9115718198182583,"['DGAT2', 'LPL', 'AGPAT1', 'PLPP1']",0.9967659009132112,0,0,4
222,Vitamin D in inflammatory diseases WP4482,0.4656460640764837,1.1926425401160805,0.9115718198182583,"['NFKBIA', 'DUSP1', 'NR3C1', 'NFKB1']",0.9967659009132112,0,0,4
223,Development of ureteric collection system WP5053,0.46585246711687867,1.1131578947368421,0.8503260534516626,"['RET', 'ITGB1', 'GRIP1', 'FRAS1', 'GREB1L', 'ITGA8', 'ETV4']",0.9967659009132112,0,0,7
224,Fragile X Syndrome  WP4549,0.4679138392764355,1.0436448317307692,0.7926180926677826,"['CYFIP1', 'EPHA4', 'KCND2', 'CAMK2A', 'AGAP2', 'PTEN', 'GAB1', 'CLTA', 'BRAF', 'AKAP5', 'GRIP2', 'TTI1', 'EEF1A1', 'GRIP1', 'GRM5', 'SYNGAP1', 'ALDH5A1', 'PRKACA', 'SOS1', 'PTPN5', 'PDK1']",0.9967659009132112,0,0,21
225,Wnt signaling WP428,0.4709021691065491,1.0472576664017068,0.7886948963030082,"['PRKCG', 'WNT10B', 'GSK3B', 'WNT10A', 'CSNK2A1', 'PRKCB', 'CAMK2A', 'PRICKLE2', 'CXXC4', 'DKK2', 'RHOA', 'PORCN', 'PLCB3', 'CCND2', 'PLCB4', 'ROR1', 'RAC1', 'NOTUM']",0.9967659009132112,0,0,18
226,Signal transduction through IL1R WP4496,0.47821490801476807,1.135831381733021,0.8378971869991909,"['NFKBIA', 'IL1R1', 'TRAF6', 'ECSIT', 'NFKB1']",0.9967659009132112,0,0,5
227,White fat cell differentiation WP4149,0.47821490801476807,1.135831381733021,0.8378971869991909,"['WNT10B', 'EGR2', 'RORA', 'PPARG', 'NR3C1']",0.9967659009132112,0,0,5
228,15q11.2 copy number variation syndrome WP4940,0.4794909687652158,1.3629672954135594,1.0018221503572544,"['CYFIP1', 'TUBGCP4']",0.9967659009132112,0,0,2
229,"Degradation pathway of sphingolipids, including diseases WP4153",0.4794909687652158,1.3629672954135594,1.0018221503572544,"['NEU3', 'GM2A']",0.9967659009132112,0,0,2
230,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.4794909687652158,1.3629672954135594,1.0018221503572544,"['STAT1', 'BLVRA']",0.9967659009132112,0,0,2
231,Leptin and adiponectin WP3934,0.4794909687652158,1.3629672954135594,1.0018221503572544,"['PRKAG1', 'ACACA']",0.9967659009132112,0,0,2
232,Thiamine metabolic pathways WP4297,0.4794909687652158,1.3629672954135594,1.0018221503572544,"['BCKDHA', 'SLC25A19']",0.9967659009132112,0,0,2
233,Nonalcoholic fatty liver disease WP4396,0.48099142201473627,1.0315052075107076,0.7549646881366717,"['GSK3B', 'NDUFB6', 'IRS1', 'EIF2AK3', 'PRKAG1', 'PIK3R3', 'PIK3CD', 'SDHC', 'TRAF2', 'SDHD', 'SDHB', 'COX7B2', 'EIF2S1', 'NFKB1', 'CDC42', 'COX7A2L', 'PIK3CA', 'AKT3', 'NDUFS1', 'UQCRC2', 'NDUFV3', 'RAC1', 'NDUFV1', 'ATF4']",0.9967659009132112,0,0,24
234,Mitochondrial CIV Assembly WP4922,0.4878905359773938,1.1008646290504849,0.7900511441178446,"['TMEM177', 'PNKD', 'COX16', 'COX15', 'COX11', 'SMIM20']",0.9967659009132112,0,0,6
235,ESC Pluripotency Pathways WP3931,0.48920112050393244,1.034565707082188,0.7396954287149953,"['PDGFRB', 'WNT10B', 'GSK3B', 'ACTR2', 'WNT10A', 'FZD4', 'PTEN', 'GAB1', 'PIK3CD', 'BRAF', 'FOS', 'FGF1', 'FGF14', 'AKT3', 'SOS1', 'FGF12', 'FGF22', 'FGF10']",0.9967659009132112,0,0,18
236,DNA IR-damage and cellular response via ATR WP4016,0.48927020967561696,1.0435401678657075,0.745964635634487,"['MDC1', 'PARP1', 'RMI1', 'XRCC5', 'RECQL', 'PPM1D', 'CHEK1', 'E2F1', 'CDK1', 'RAD1', 'CLSPN', 'EEF1E1', 'ATRIP', 'MCPH1']",0.9967659009132112,0,0,14
237,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4946305876983754,1.0088713906883637,0.7101890454812431,"['ITGB1', 'GSK3B', 'SRP54', 'HMGB1', 'SLC8A1', 'RND1', 'TUBB8', 'RPS6KA5', 'PSMD4', 'ITGAV', 'RAC1', 'MAP2K4', 'HSP90AA1', 'PRKCB', 'TPM3', 'PRKCD', 'SSR3', 'GAB1', 'ADAM10', 'PDIA6', 'RHOA', 'INPP4B', 'PLCB3', 'PIK3CA', 'FSCN1', 'MYH9', 'SLC25A11', 'ATF4', 'NAPA', 'LRRC59', 'EPB41', 'PXN', 'PTGS2', 'ACACB', 'NDRG1', 'ACACA', 'CAMKK2', 'CDC42', 'DLL4', 'STIP1', 'PAK1', 'RAP1A', 'DHX36', 'RICTOR', 'ASCC3', 'ZC3H15', 'TXNDC5', 'DECR1', 'STAT1', 'SIAH2', 'IDH2', 'EIF2AK3', 'PDE4DIP', 'NFKB1', 'NFKBIA', 'AFDN', 'TFCP2', 'GIPC1', 'CALU', 'NOX4', 'HYOU1', 'TPP1', 'P4HB', 'EIF3F', 'CALR', 'GRSF1', 'RAB5A', 'EIF3D', 'EIF4G2', 'HSPA1A']",0.9967659009132112,0,0,70
238,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4957948104312452,1.077172403148634,0.7557367541009574,"['CASP9', 'MAP2K4', 'ACTA1', 'PAK1', 'PARP1', 'CASP6', 'SPTAN1']",0.9967659009132112,0,0,7
239,Blood Clotting Cascade WP272,0.49589746645076105,1.1925767918088737,0.8364567783889991,"['F8', 'F11', 'KLKB1']",0.9967659009132112,0,0,3
240,Hypertrophy Model WP516,0.49589746645076105,1.1925767918088737,0.8364567783889991,"['ZEB1', 'IL1R1', 'ADAM10']",0.9967659009132112,0,0,3
241,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.49589746645076105,1.1925767918088737,0.8364567783889991,"['GSK3B', 'RHOA', 'MAP3K4']",0.9967659009132112,0,0,3
242,Mitochondrial complex III assembly WP4921,0.49589746645076105,1.1925767918088737,0.8364567783889991,"['UQCC2', 'LYRM7', 'UQCRC2']",0.9967659009132112,0,0,3
243,Overview of nanoparticle effects WP3287,0.49589746645076105,1.1925767918088737,0.8364567783889991,"['AKT3', 'PIK3CD', 'PTGS2']",0.9967659009132112,0,0,3
244,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.49589746645076105,1.1925767918088737,0.8364567783889991,"['GSK3B', 'TNKS', 'TCF4']",0.9967659009132112,0,0,3
245,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.502509424712595,1.0600569800569801,0.7294685468992628,"['LAG3', 'STAT1', 'TRAF6', 'DHX58', 'TRAF5', 'TRAF2', 'NFKB1', 'IFNAR1']",0.9967659009132112,0,0,8
246,Immune response to tuberculosis WP4197,0.5061334203764439,1.1224067640029722,0.7643084618603013,"['STAT1', 'IFNGR2', 'JAK2', 'IFNAR1']",0.9967659009132112,0,0,4
247,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5061334203764439,1.1224067640029722,0.7643084618603013,"['G6PD', 'PARP1', 'MDH2', 'SIRT5']",0.9967659009132112,0,0,4
248,Wnt Signaling Pathway WP363,0.5083722151748004,1.0471122084681859,0.7084147517940085,"['PRKCG', 'GSK3B', 'PRKCB', 'PPARG', 'ROR1', 'PIP5K1B', 'TCF4', 'RAC1', 'RHOA']",0.9967659009132112,0,0,9
249,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5124498821462896,1.0131024559119242,0.6773120415554897,"['MAP2K4', 'WNT10B', 'GSK3B', 'WNT10A', 'FZD4', 'PDCD6', 'PIK3R3', 'PIK3CD', 'PROX1', 'NR2C2', 'DLL1', 'DLL4', 'TJP1', 'ZEB2', 'PAK1', 'ZEB1', 'FMNL2', 'PIK3CA', 'RBBP4', 'TRAF6', 'AKT3', 'PKP1', 'SOS1', 'SOS2']",0.9967659009132112,0,0,24
250,Mesodermal commitment pathway WP2857,0.5184363109943135,1.0118006993006994,0.6646904209240969,"['HES7', 'VAV3', 'WDHD1', 'FZD4', 'NCAPG2', 'ARID5B', 'PHF6', 'DLL1', 'ACACA', 'PARP8', 'ARL4A', 'WDCP', 'UBR5', 'CCDC6', 'TCF4', 'HPRT1', 'ASCC3', 'PRKACA', 'JAK2', 'JARID2', 'TEAD1']",0.9967659009132112,0,0,21
251,MAPK Cascade WP422,0.5199271661003434,1.060015943514406,0.6933209630721991,"['MAPK10', 'MAP2K4', 'PLCB3', 'BRAF', 'SOS1', 'SOS2']",0.9967659009132112,0,0,6
252,Regulation of Actin Cytoskeleton WP51,0.5280371196047385,1.0041432215809376,0.6412345099296579,"['PDGFRB', 'PXN', 'PIK3R3', 'PIK3CD', 'BRAF', 'FGF1', 'RHOA', 'VAV1', 'CDC42', 'GNA13', 'PAK1', 'FGF14', 'MRAS', 'PIK3CA', 'ABI2', 'RAC2', 'PIP5K1B', 'RAC1', 'SOS1', 'FGF12', 'SOS2', 'FGF22', 'FGF10', 'ARHGEF6']",0.9967659009132112,0,0,24
253,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.5330093718688769,1.5900409276944065,1.00047962441754,['NFKB1'],0.9967659009132112,0,0,1
254,Aflatoxin B1 metabolism WP699,0.5330093718688769,1.5900409276944065,1.00047962441754,['AKR7A2'],0.9967659009132112,0,0,1
255,Gastric acid production WP2596,0.5330093718688769,1.5900409276944065,1.00047962441754,['GRP'],0.9967659009132112,0,0,1
256,Hypothetical Craniofacial Development Pathway WP3655,0.5330093718688769,1.5900409276944065,1.00047962441754,['RHOA'],0.9967659009132112,0,0,1
257,Nanomaterial-induced inflammasome activation WP3890,0.5330093718688769,1.5900409276944065,1.00047962441754,['NFKB1'],0.9967659009132112,0,0,1
258,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.5330093718688769,1.5900409276944065,1.00047962441754,['CCKBR'],0.9967659009132112,0,0,1
259,Steroid Biosynthesis WP496,0.5330093718688769,1.5900409276944065,1.00047962441754,['HSD17B1'],0.9967659009132112,0,0,1
260,Vitamin B6-dependent and responsive disorders WP4228,0.5330093718688769,1.5900409276944065,1.00047962441754,['PIGV'],0.9967659009132112,0,0,1
261,Interferon type I signaling pathways WP585,0.5339787125477586,1.0221076802814149,0.6412696482021347,"['ZAP70', 'RPS6KA5', 'RAP1A', 'IRS1', 'STAT1', 'PIK3CD', 'RAC1', 'VAV1', 'IFNAR1']",0.9967659009132112,0,0,9
262,ACE Inhibitor Pathway WP554,0.5384812095268943,1.1925110883657455,0.7381675561638471,"['REN', 'NR3C2']",0.9967659009132112,0,0,2
263,Autosomal recessive Osteopetrosis pathways WP4788,0.5384812095268943,1.1925110883657455,0.7381675561638471,"['TRAF6', 'NFKB1']",0.9967659009132112,0,0,2
264,Cytokines and Inflammatory Response WP530,0.5384812095268943,1.1925110883657455,0.7381675561638471,"['IL11', 'IL15']",0.9967659009132112,0,0,2
265,Dopamine metabolism WP2436,0.5384812095268943,1.1925110883657455,0.7381675561638471,"['PPP2CB', 'PRKACA']",0.9967659009132112,0,0,2
266,EDA signaling in hair follicle development WP3930,0.5384812095268943,1.1925110883657455,0.7381675561638471,"['EDA', 'LTB']",0.9967659009132112,0,0,2
267,LTF danger signal response pathway WP4478,0.5384812095268943,1.1925110883657455,0.7381675561638471,"['TRAF6', 'NFKB1']",0.9967659009132112,0,0,2
268,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5384812095268943,1.1925110883657455,0.7381675561638471,"['BHMT', 'GNMT']",0.9967659009132112,0,0,2
269,TCA cycle in senescence WP5050,0.5384812095268943,1.1925110883657455,0.7381675561638471,"['BRAF', 'PDK1']",0.9967659009132112,0,0,2
270,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.5419590229967939,1.1007613546862693,0.6742877512451364,"['RBBP4', 'THRAP3', 'JARID2']",0.9967659009132112,0,0,3
271,1q21.1 copy number variation syndrome WP4905,0.5451826402813699,1.0599749630135427,0.6430172976194793,"['TJP1', 'PYGO2', 'AFDN', 'PRKAG1']",0.9967659009132112,0,0,4
272,NAD+ biosynthetic pathways WP3645,0.5451826402813699,1.0599749630135427,0.6430172976194793,"['PARP1', 'TNKS', 'SIRT5', 'SIRT6']",0.9967659009132112,0,0,4
273,Nanoparticle triggered autophagic cell death WP2509,0.5451826402813699,1.0599749630135427,0.6430172976194793,"['BECN1', 'UVRAG', 'CHAF1A', 'ATG9B']",0.9967659009132112,0,0,4
274,T-cell receptor (TCR) signaling pathway WP69,0.5476541269236666,1.000060760053027,0.6021479308625715,"['VAV3', 'ITK', 'DBNL', 'PRKCD', 'FOS', 'VAV1', 'NFKB1', 'CDC42', 'NFKBIA', 'ZAP70', 'PAK1', 'TRAF6', 'SOS1']",0.9967659009132112,0,0,13
275,Aryl Hydrocarbon Receptor Pathway WP2873,0.548237367685756,1.0369149441672607,0.6232345470839704,"['NCOA1', 'HSP90AA1', 'PTGES3', 'MYOF', 'CAP2']",0.9967659009132112,0,0,5
276,Aryl Hydrocarbon Receptor Netpath WP2586,0.5539077962661642,1.0117442366246194,0.5976950292704214,"['RET', 'HSP90AA1', 'KLF6', 'E2F1', 'LPL', 'PTGS2', 'NFKB1']",0.9967659009132112,0,0,7
277,DNA Replication WP466,0.5539077962661642,1.0117442366246194,0.5976950292704214,"['PRIM2', 'ORC6', 'ORC1', 'RFC2', 'POLD1', 'MCM4', 'MCM10']",0.9967659009132112,0,0,7
278,One-carbon metabolism and related pathways WP3940,0.5565517675828933,1.0041205578047683,0.5884097157215934,"['DMGDH', 'BHMT', 'AHCYL1', 'GPX3', 'BHMT2', 'GSS', 'GPX7', 'GNMT']",0.9967659009132112,0,0,8
279,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5615203184619013,0.9936281217926788,0.5734300618656699,"['GSK3B', 'ACTR2', 'MAP2K4', 'ACTA1', 'PAK1', 'FZD4', 'ERBB2', 'TGFA', 'SOS1', 'RHOA']",0.9967659009132112,0,0,10
280,Ebola Virus Pathway on Host WP4217,0.5633029832107334,0.9849116707946645,0.5652778771292397,"['ITGB1', 'STAT1', 'VPS33A', 'PIK3R3', 'CLTA', 'PIK3CD', 'EIF2S1', 'NFKB1', 'RHOA', 'IGF1R', 'RHOB', 'CDC42', 'PAK1', 'PIK3CA', 'CTSL', 'ITGAV', 'RAC1', 'TOP1', 'RAB5A']",0.9967659009132112,0,0,19
281,Sphingolipid pathway WP1422,0.5814983687786309,0.9936390027322405,0.5386985159235967,"['ASAH1', 'SGPL1', 'GAL3ST1', 'SGMS2', 'PLPP1']",0.9967659009132112,0,0,5
282,Metabolic reprogramming in colon cancer WP4290,0.5818382804594552,0.9819166901210244,0.5317694916706887,"['G6PD', 'MDH2', 'IDH2', 'TALDO1', 'PDHB', 'SDHB', 'GLS']",0.9967659009132112,0,0,7
283,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5825611687762321,1.0041149305493162,0.5425444720334862,"['TGFBR3', 'NR2C2', 'LTBP1', 'FBN1']",0.9967659009132112,0,0,4
284,PPAR signaling pathway WP3942,0.5836143852009533,0.975508332296978,0.5253256876940582,"['RXRB', 'CPT2', 'FABP7', 'OLR1', 'APOA1', 'LPL', 'PPARG', 'CPT1B', 'SLC27A5']",0.9967659009132112,0,0,9
285,BMP Signaling Pathway in Eyelid Development WP3927,0.5854773858247062,1.0220624085811798,0.5471383392805175,"['TGFA', 'DKK2', 'FGF10']",0.9967659009132112,0,0,3
286,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5854773858247062,1.0220624085811798,0.5471383392805175,"['CYP24A1', 'ALPL', 'NFKB1']",0.9967659009132112,0,0,3
287,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.5854773858247062,1.0220624085811798,0.5471383392805175,"['TJP1', 'PXN', 'ITGAV']",0.9967659009132112,0,0,3
288,PPAR-alpha pathway WP2878,0.5854773858247062,1.0220624085811798,0.5471383392805175,"['CPT2', 'CDK1', 'APOA1']",0.9967659009132112,0,0,3
289,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5859815803875784,0.9714617081146856,0.5192141496422212,"['ITGB1', 'LAMA5', 'INF2', 'NPHS1', 'CTSL', 'PODXL', 'KRT8', 'FAT1', 'MYH9', 'ITGAV', 'CD2AP']",0.9967659009132112,0,0,11
290,Head and Neck Squamous Cell Carcinoma WP4674,0.5872751415868431,0.9699487637737251,0.5162667175443145,"['PIK3CA', 'TERT', 'SESN2', 'AKT3', 'ERBB2', 'PTEN', 'GAB1', 'E2F1', 'FAT1', 'RICTOR', 'NFKB1', 'IGF1R']",0.9967659009132112,0,0,12
291,Alzheimer's disease WP2059,0.5886103614951207,0.968669734589041,0.5133860860367514,"['GSK3B', 'PSEN2', 'EIF2AK3', 'ADAM10', 'ITPR2', 'LPL', 'IDE', 'CASP9', 'BACE1', 'PLCB3', 'NCSTN', 'PLCB4', 'MAPT']",0.9967659009132112,0,0,13
292,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.5886103614951207,0.968669734589041,0.5133860860367514,"['GSK3B', 'MAP2K4', 'PRKCB', 'PIK3CD', 'PIK3R3', 'NRG1', 'RHOA', 'NFKB1', 'IGF1R', 'CDK7', 'PIK3CA', 'NPPA', 'RAC1']",0.9967659009132112,0,0,13
293,Biogenic Amine Synthesis WP550,0.5926664346141528,1.0599340384396678,0.5544764496579666,"['AANAT', 'PAH']",0.9967659009132112,0,0,2
294,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.5926664346141528,1.0599340384396678,0.5544764496579666,"['BATF3', 'TCF4']",0.9967659009132112,0,0,2
295,Neuroinflammation WP4919,0.5926664346141528,1.0599340384396678,0.5544764496579666,"['NFKBIA', 'FOS']",0.9967659009132112,0,0,2
296,Osteoblast Signaling WP322,0.5926664346141528,1.0599340384396678,0.5544764496579666,"['PDGFRB', 'ITGAV']",0.9967659009132112,0,0,2
297,Osteopontin Signaling WP1434,0.5926664346141528,1.0599340384396678,0.5544764496579666,"['ITGAV', 'NFKB1']",0.9967659009132112,0,0,2
298,Sulfation Biotransformation Reaction WP692,0.5926664346141528,1.0599340384396678,0.5544764496579666,"['SULT1A1', 'G6PD']",0.9967659009132112,0,0,2
299,Transcriptional cascade regulating adipogenesis WP4211,0.5926664346141528,1.0599340384396678,0.5544764496579666,"['EGR2', 'PPARG']",0.9967659009132112,0,0,2
300,Vitamin B12 Disorders WP4271,0.5926664346141528,1.0599340384396678,0.5544764496579666,"['CUBN', 'MMACHC']",0.9967659009132112,0,0,2
301,Cell cycle WP179,0.5969000557387486,0.9638173746696067,0.49733515348034346,"['GSK3B', 'YWHAZ', 'RBX1', 'CDK7', 'STAG1', 'CCND2', 'ORC6', 'STAG2', 'ORC1', 'TFDP2', 'CDC27', 'CHEK1', 'CDK1', 'E2F1', 'MCM4', 'E2F3', 'SKP2', 'E2F5', 'BUB1']",0.9967659009132112,0,0,19
302,DNA IR-double strand breaks and cellular response via ATM WP3959,0.6074963247244761,0.9537619699042408,0.47536369617681185,"['CASP9', 'MDC1', 'RASSF1', 'PARP1', 'TRAF6', 'CHEK1', 'RNF8', 'E2F1', 'MCPH1']",0.9967659009132112,0,0,9
303,Prader-Willi and Angelman Syndrome WP3998,0.6074963247244761,0.9537619699042408,0.47536369617681185,"['KISS1', 'PCSK1', 'CYFIP1', 'NHLH2', 'SLC45A2', 'CCND2', 'SNRPN', 'E2F1', 'BBS4']",0.9967659009132112,0,0,9
304,Acute viral myocarditis WP4298,0.6075877989034375,0.9537303216974675,0.4752043246294051,"['CASP9', 'GSK3B', 'PARP1', 'CASP6', 'STAT1', 'RAC2', 'KRT8', 'CASP2', 'ABL2', 'SOS1', 'EIF4G2']",0.9967659009132112,0,0,11
305,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.607938829774859,0.9537777777777777,0.4746770887140796,"['GSK3B', 'SYNGAP1', 'PIK3CA', 'AKT3', 'PRKAG1', 'PTEN', 'PIK3CD', 'PIK3R3']",0.9967659009132112,0,0,8
306,Notch Signaling WP268,0.6088857051228802,0.9537935748462064,0.47320055614485457,"['DLL4', 'KAT2B', 'NUMBL', 'NCSTN', 'PSEN2', 'DTX4', 'DLL1']",0.9967659009132112,0,0,7
307,Androgen receptor signaling pathway WP138,0.6091119142107967,0.9536827680712573,0.4727913422101884,"['NCOA1', 'GSK3B', 'NCOA2', 'PTEN', 'RNF4', 'NR2C2', 'RHOA', 'RHOB', 'CDC42', 'KAT2B', 'KAT7', 'RAC1', 'CALR', 'PLPP1']",0.9967659009132112,0,0,14
308,IL-2 signaling pathway WP49,0.6105710653161193,0.9538093611206013,0.4705719463855741,"['CCND2', 'STAT1', 'FOS', 'MAPT', 'SOS1', 'JAK3']",0.9967659009132112,0,0,6
309,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6133937230296791,0.9538251366120218,0.46618037627619746,"['PIK3CA', 'TRAF6', 'LY96', 'NFKB1', 'RHOA']",0.9967659009132112,0,0,5
310,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6133937230296791,0.9538251366120218,0.46618037627619746,"['CASP9', 'NFKBIA', 'HSP90AA1', 'ERBIN', 'RAC1']",0.9967659009132112,0,0,5
311,Tumor suppressor activity of SMARCB1 WP4204,0.6133937230296791,0.9538251366120218,0.46618037627619746,"['SMARCD1', 'SMARCD3', 'RBBP4', 'DPF2', 'ARID1B']",0.9967659009132112,0,0,5
312,Benzene metabolism WP3891,0.6139693192565903,1.1924454297407914,0.581687187524079,['DHDH'],0.9967659009132112,0,0,1
313,EV release from cardiac cells and their functional effects WP3297,0.6139693192565903,1.1924454297407914,0.581687187524079,['MYB'],0.9967659009132112,0,0,1
314,Hfe effect on hepcidin production WP3924,0.6139693192565903,1.1924454297407914,0.581687187524079,['HJV'],0.9967659009132112,0,0,1
315,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.6139693192565903,1.1924454297407914,0.581687187524079,['RAC1'],0.9967659009132112,0,0,1
316,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.6139693192565903,1.1924454297407914,0.581687187524079,['REN'],0.9967659009132112,0,0,1
317,mRNA Processing WP411,0.6152221309149943,0.9535714285714286,0.463218193113044,"['SNRPN', 'DHX8', 'CPSF1', 'PRMT2', 'RNMT', 'CPSF3', 'SRP54', 'CSTF2T', 'PTBP2', 'PRPF4', 'PHF5A', 'CLP1', 'CSTF1', 'SNRPA1', 'SNRPD3', 'SNRPF', 'SREK1', 'CLASRP', 'TXNL4A', 'RBMX', 'SNRPA']",0.9967659009132112,0,0,21
318,TGF-beta Signaling Pathway WP366,0.6152221309149943,0.9535714285714286,0.463218193113044,"['ITGB1', 'MAP2K4', 'SMURF2', 'TNC', 'WWP1', 'FOS', 'RHOA', 'RBX1', 'TGFBR3', 'CDC42', 'ZEB2', 'KLF6', 'ZEB1', 'TERT', 'TRAF6', 'CDK1', 'SNIP1', 'RAC1', 'SOS1', 'E2F5', 'PDK1']",0.9967659009132112,0,0,21
319,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6180960937948982,0.9538409013315124,0.4589036761270044,"['RBBP4', 'CBX3', 'SUV39H1', 'E2F1']",0.9967659009132112,0,0,4
320,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.6180960937948982,0.9538409013315124,0.4589036761270044,"['CYP24A1', 'ABCB4', 'PPARG', 'ABCB11']",0.9967659009132112,0,0,4
321,Physiological and pathological hypertrophy of the heart WP1528,0.6180960937948982,0.9538409013315124,0.4589036761270044,"['PRKCB', 'RAC1', 'FOS', 'RHOA']",0.9967659009132112,0,0,4
322,15q13.3 copy number variation syndrome WP4942,0.6262498358254684,0.9538566552901024,0.4464105316877362,"['KAT2B', 'MTMR10', 'SERPINH1']",0.9967659009132112,0,0,3
323,IL1 and megakaryocytes in obesity WP2865,0.6262498358254684,0.9538566552901024,0.4464105316877362,"['PIK3CA', 'IL1R1', 'NFKB1']",0.9967659009132112,0,0,3
324,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6262498358254684,0.9538566552901024,0.4464105316877362,"['MRAS', 'BRAF', 'RAB5A']",0.9967659009132112,0,0,3
325,Transcription factor regulation in adipogenesis WP3599,0.6262498358254684,0.9538566552901024,0.4464105316877362,"['IRS1', 'PPARG', 'NR3C1']",0.9967659009132112,0,0,3
326,Osteoblast differentiation WP4787,0.6284822132114775,0.9424785465913803,0.43773185352412025,"['PRKCG', 'WNT10B', 'WNT10A', 'PRKCB', 'FZD4', 'STAT1', 'PRKCD', 'PIK3R3', 'PIK3CD', 'FGF1', 'DLL1', 'DLL4', 'MAPK10', 'HEY1', 'PIK3CA', 'PPARG', 'FGF10']",0.9967659009132112,0,0,17
327,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6306718333923804,0.932961101528579,0.4300667296610553,"['ACAN', 'THRA', 'STAT1', 'SERPINH1', 'COL10A1', 'ALPL', 'PRKACA', 'IGF1R', 'SOX5']",0.9967659009132112,0,0,9
328,Endochondral Ossification WP474,0.6306718333923804,0.932961101528579,0.4300667296610553,"['ACAN', 'THRA', 'STAT1', 'SERPINH1', 'COL10A1', 'ALPL', 'PRKACA', 'IGF1R', 'SOX5']",0.9967659009132112,0,0,9
329,IL-3 signaling pathway WP286,0.6349711924049934,0.9272328548644339,0.4211265821577615,"['INPP5D', 'PIK3CD', 'FOS', 'JAK2', 'PRKACA', 'SOS1', 'VAV1']",0.9967659009132112,0,0,7
330,Netrin-UNC5B signaling pathway WP4747,0.6349711924049934,0.9272328548644339,0.4211265821577615,"['PIK3CA', 'INPP5D', 'AGAP2', 'ALPL', 'RAC1', 'NEO1', 'RHOA']",0.9967659009132112,0,0,7
331,IL-5 signaling pathway WP127,0.6385810960251497,0.922975192038529,0.41396046651632656,"['GSK3B', 'STAT1', 'FOS', 'MAPT', 'JAK2', 'SOS1']",0.9967659009132112,0,0,6
332,Disorders of Folate Metabolism and Transport WP4259,0.6419397053764838,0.9538723984988059,0.4228143345640396,"['ATIC', 'FTCD']",0.9967659009132112,0,0,2
333,Drug Induction of Bile Acid Pathway WP2289,0.6419397053764838,0.9538723984988059,0.4228143345640396,"['ABCC4', 'ABCB11']",0.9967659009132112,0,0,2
334,Osteoclast Signaling WP12,0.6419397053764838,0.9538723984988059,0.4228143345640396,"['AIMP2', 'IFNAR1']",0.9967659009132112,0,0,2
335,Serotonin and anxiety-related events WP3944,0.6419397053764838,0.9538723984988059,0.4228143345640396,"['PRKCB', 'FOS']",0.9967659009132112,0,0,2
336,Fluoropyrimidine Activity WP1601,0.6438168651092464,0.9170738755779739,0.40382519467630335,"['ABCC4', 'RRM2', 'ERCC2', 'GGH', 'CES2']",0.9967659009132112,0,0,5
337,Wnt signaling in kidney disease WP4150,0.6438168651092464,0.9170738755779739,0.40382519467630335,"['MAPK10', 'WNT10B', 'WNT10A', 'FZD4', 'RHOA']",0.9967659009132112,0,0,5
338,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.6455400994866302,0.9356128684399713,0.4094877652203742,"['RET', 'RYR2', 'NFYA', 'CDCA7L', 'MBD1', 'RORA', 'SSTR1', 'NR3C1', 'ASCL1', 'YWHAZ', 'NFKB1', 'GCK', 'HSPD1', 'ADCYAP1', 'PRKAR2B', 'PAH', 'MYB', 'SP3', 'SCN5A', 'PRKACA', 'SCN3B']",0.9967659009132112,0,0,21
339,AMP-activated protein kinase (AMPK) signaling WP1403,0.6508202868677772,0.9169320245269612,0.3938422312305481,"['GYS2', 'PIK3CA', 'PRKAG1', 'PIK3CD', 'PIK3R3', 'CPT1B', 'ACACB', 'ACACA', 'SLC2A4RG', 'CAMKK2']",0.9967659009132112,0,0,10
340,Monoamine Transport WP727,0.651668101731058,0.9083548748963566,0.3889756274144077,"['PPP2CB', 'IL1R1', 'AMPH', 'STX1A']",0.9967659009132112,0,0,4
341,Calcium Regulation in the Cardiac Cell WP536,0.6602222221123341,0.9280392043606339,0.3853022036483839,"['PRKCG', 'RYR2', 'PRKCB', 'PRKCD', 'CAMK2A', 'ITPR2', 'ATP2B3', 'ADRA1D', 'ATP2B2', 'ADCY1', 'ADCY8', 'YWHAZ', 'ADCY7', 'SLC8A1', 'PLCB3', 'RGS3', 'ADCY9', 'PRKAR2B', 'GNB1', 'CALR', 'GNB5', 'PRKACA']",0.9967659009132112,0,0,22
342,Senescence and Autophagy in Cancer WP615,0.6638863780481091,0.9142932229558819,0.37453497215370907,"['UVRAG', 'GSK3B', 'BECN1', 'PTEN', 'BRAF', 'IGF1R', 'ING2', 'CREG1', 'E2F1', 'COL10A1', 'SLC39A1', 'SQSTM1', 'SLC39A4', 'SLC39A3']",0.9967659009132112,0,0,14
343,Inflammatory Response Pathway WP453,0.6641682819637897,0.8941766211604095,0.365914710943753,"['LAMA5', 'ZAP70', 'LAMC1']",0.9967659009132112,0,0,3
344,ATM Signaling Pathway WP2516,0.6653535031181077,0.894068158524086,0.3642762658525896,"['NFKBIA', 'MDC1', 'CRADD', 'CHEK1', 'CDK1', 'CASP2']",0.9967659009132112,0,0,6
345,Glycolysis and Gluconeogenesis WP534,0.6653535031181077,0.894068158524086,0.3642762658525896,"['MPC1', 'MDH2', 'DLD', 'GCK', 'PFKP', 'FBP2']",0.9967659009132112,0,0,6
346,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6714857669095825,0.8995668704290629,0.3582637140394497,"['ITGB1', 'CASP9', 'NFKBIA', 'PAK1', 'PIK3CA', 'PXN', 'ERBB2', 'RAC1', 'SOS1', 'NFKB1']",0.9967659009132112,0,0,10
347,Endoderm differentiation WP2853,0.6756544910793514,0.9148104240760383,0.3586728712602191,"['VAV3', 'WDHD1', 'STAT1', 'SIAH2', 'CTR9', 'NCAPG2', 'RTF1', 'LAMC1', 'NR3C1', 'PHF6', 'ACACA', 'PARP8', 'RFX7', 'SP4', 'UBR5', 'TCF4', 'HPRT1', 'ASCC3', 'JARID2']",0.9967659009132112,0,0,19
348,Cellular Proteostasis WP4918,0.6808975359658839,0.9538881309686221,0.36662065067750094,['PFDN1'],0.9967659009132112,0,0,1
349,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.6808975359658839,0.9538881309686221,0.36662065067750094,['PPARG'],0.9967659009132112,0,0,1
350,Fluoroacetic acid toxicity WP4966,0.6808975359658839,0.9538881309686221,0.36662065067750094,['ACSS2'],0.9967659009132112,0,0,1
351,FTO Obesity Variant Mechanism WP3407,0.6808975359658839,0.9538881309686221,0.36662065067750094,['ARID5B'],0.9967659009132112,0,0,1
352,Metabolism of alpha-linolenic acid WP4586,0.6808975359658839,0.9538881309686221,0.36662065067750094,['PTGS2'],0.9967659009132112,0,0,1
353,Molybdenum cofactor (Moco) biosynthesis WP4507,0.6808975359658839,0.9538881309686221,0.36662065067750094,['SUOX'],0.9967659009132112,0,0,1
354,Peroxiredoxin 2 induced ovarian failure WP4873,0.6808975359658839,0.9538881309686221,0.36662065067750094,['MAPK10'],0.9967659009132112,0,0,1
355,SARS-CoV-2 and COVID-19 Pathway WP4846,0.6808975359658839,0.9538881309686221,0.36662065067750094,['CTSL'],0.9967659009132112,0,0,1
356,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.6811741679183504,0.9018730961177004,0.34626267848985753,"['NDUFB6', 'COX15', 'SDHC', 'SDHD', 'ATP5F1C', 'SDHB', 'COX7A2L', 'SCO1', 'COX11', 'NDUFS1', 'UQCRC2', 'NDUFV3', 'NDUFV1', 'ATP5MG']",0.9967659009132112,0,0,14
357,Neural Crest Differentiation WP2064,0.6830585218256178,0.8981536628945801,0.34235348856485226,"['ITGB1', 'GSK3B', 'HDAC11', 'ASCL1', 'DLL1', 'NFKB1', 'RHOB', 'DLL4', 'PAX7', 'MPZ', 'MYB', 'TCF4', 'SOX5']",0.9967659009132112,0,0,13
358,Pyrimidine metabolism WP4022,0.6830585218256178,0.8981536628945801,0.34235348856485226,"['PRIM2', 'DUT', 'RRM2', 'POLR3GL', 'DCTD', 'POLR3A', 'POLD1', 'POLR3D', 'POLR2D', 'TWISTNB', 'POLR3F', 'POLR1E', 'TK2']",0.9967659009132112,0,0,13
359,7-oxo-C and 7beta-HC pathways WP5064,0.6832050172363413,0.8670039417734877,0.33029407552088663,"['ACOT8', 'ACOT7', 'ACOT13', 'SLC27A5']",0.9967659009132112,0,0,4
360,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.6863754415721892,0.867094693092646,0.3263141881077836,"['TNC', 'VHL']",0.9967659009132112,0,0,2
361,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6863754415721892,0.867094693092646,0.3263141881077836,"['RYR2', 'CCKBR']",0.9967659009132112,0,0,2
362,IL-9 signaling pathway WP22,0.6863754415721892,0.867094693092646,0.3263141881077836,"['STAT1', 'JAK3']",0.9967659009132112,0,0,2
363,Nephrogenesis WP5052,0.6863754415721892,0.867094693092646,0.3263141881077836,"['GREB1L', 'RSPO3']",0.9967659009132112,0,0,2
364,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6863754415721892,0.867094693092646,0.3263141881077836,"['STAG1', 'BUB1']",0.9967659009132112,0,0,2
365,Methionine De Novo and Salvage Pathway WP3580,0.6992015793497603,0.8415177675165629,0.3011086863112265,"['BHMT', 'ENOPH1', 'SRM']",0.9967659009132112,0,0,3
366,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6992015793497603,0.8415177675165629,0.3011086863112265,"['GSK3B', 'CYP24A1', 'PIK3CA']",0.9967659009132112,0,0,3
367,Histone Modifications WP2369,0.70689681445755,0.8557232241442768,0.29682520437853127,"['KMT2E', 'KMT5C', 'SUV39H1', 'EHMT2', 'PRDM2', 'HIST1H4C', 'HIST1H4E']",0.9967659009132112,0,0,7
368,Gastric Cancer Network 2 WP2363,0.7126752725241517,0.8292487419656508,0.2808909292864581,"['OTUD5', 'AHCTF1', 'DSCC1', 'BRIX1']",0.9967659009132112,0,0,4
369,Parkinson's disease pathway WP2371,0.7256319263795175,0.8220275108347466,0.26363440039314995,"['CASP9', 'CASP6', 'CASP2', 'UBE2G2', 'UBE2J2']",0.9967659009132112,0,0,5
370,Tryptophan metabolism WP465,0.7256319263795175,0.8220275108347466,0.26363440039314995,"['ECHS1', 'AANAT', 'WARS', 'AFMID', 'CAT']",0.9967659009132112,0,0,5
371,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7261698005555381,0.7947799385875128,0.25430685476130654,"['COL5A1', 'TEAD1']",0.9967659009132112,0,0,2
372,Riboflavin and CoQ disorders WP5037,0.7261698005555381,0.7947799385875128,0.25430685476130654,"['FLAD1', 'COQ7']",0.9967659009132112,0,0,2
373,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.728645423118735,0.8342703349282297,0.26410333588641755,"['TGFBR3', 'ZEB2', 'STAT1', 'FOS', 'LTBP1', 'NFKB1', 'FBN1']",0.9967659009132112,0,0,7
374,Wnt signaling pathway and pluripotency WP399,0.7298519282065163,0.8665483197857299,0.27288785397966714,"['PRKCG', 'MAP2K4', 'WNT10B', 'GSK3B', 'WNT10A', 'NFYA', 'PRKCB', 'FZD4', 'PRKCD', 'RHOA', 'MAPK10', 'PPP2CB', 'CCND2', 'PAFAH1B1']",0.9967659009132112,0,0,14
375,IL-7 signaling pathway WP205,0.7313795692849296,0.7947098976109215,0.24860330174154707,"['GSK3B', 'STAT1', 'JAK3']",0.9967659009132112,0,0,3
376,Kallmann's Syndrome WP5074,0.7313795692849296,0.7947098976109215,0.24860330174154707,"['PIK3CA', 'CHD7', 'ASCL1']",0.9967659009132112,0,0,3
377,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7321159755252301,0.8790305921863651,0.27409610293596093,"['MAP2K4', 'GSK3B', 'THRA', 'IRS1', 'PRKAG1', 'LPL', 'PIK3R3', 'PIK3CD', 'MAPK10', 'RPS6KA5', 'SESN3', 'PIK3CA', 'RPS6KA2', 'RICTOR', 'SOS1', 'MAP4K5', 'SOS2', 'MAP3K4', 'MAP4K3']",0.9967659009132112,0,0,19
378,Benzo(a)pyrene metabolism WP696,0.7362252697365604,0.794849931787176,0.24339825782938992,['AKR1A1'],0.9967659009132112,0,0,1
379,Dual hijack model of Vif in HIV infection WP3300,0.7362252697365604,0.794849931787176,0.24339825782938992,['RBX1'],0.9967659009132112,0,0,1
380,Glial Cell Differentiation WP2276,0.7362252697365604,0.794849931787176,0.24339825782938992,['GAP43'],0.9967659009132112,0,0,1
381,Ketogenesis and Ketolysis WP4742,0.7362252697365604,0.794849931787176,0.24339825782938992,['CPT2'],0.9967659009132112,0,0,1
382,Type III interferon signaling WP2113,0.7362252697365604,0.794849931787176,0.24339825782938992,['STAT1'],0.9967659009132112,0,0,1
383,One-carbon metabolism WP241,0.7400815589892658,0.7946398088084671,0.23918251707946872,"['BHMT', 'ATIC', 'AMT', 'FTCD']",0.9967659009132112,0,0,4
384,Bladder cancer WP2828,0.7496715948076271,0.7945696721311475,0.22893144725569536,"['RASSF1', 'RPS6KA5', 'ERBB2', 'E2F1', 'BRAF']",0.9967659009132112,0,0,5
385,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7496715948076271,0.7945696721311475,0.22893144725569536,"['MAPK10', 'MAP2K4', 'RPS6KA2', 'FOS', 'MAP3K4']",0.9967659009132112,0,0,5
386,Glucocorticoid Receptor Pathway WP2880,0.7526818049275025,0.824956592654951,0.23438065342517456,"['TGFBR3', 'IL11', 'HSP90AA1', 'GPR153', 'PTGES3', 'PDE4B', 'SERPINB9', 'NR3C1', 'PTGS2']",0.9967659009132112,0,0,9
387,Integrated Cancer Pathway WP1971,0.7593207018560673,0.7944994875298941,0.21875038506870045,"['CASP9', 'STAT1', 'CHEK1', 'PTEN', 'E2F1', 'CDK1']",0.9967659009132112,0,0,6
388,Statin inhibition of cholesterol production WP430,0.7607790467655511,0.752829171905874,0.20583276231258765,"['SOAT1', 'LPL', 'APOA1']",0.9967659009132112,0,0,3
389,Biomarkers for pyrimidine metabolism disorders WP4584,0.7615962660023644,0.7335905309293231,0.19978509031519953,"['RRM2', 'TK2']",0.9967659009132112,0,0,2
390,Dopaminergic Neurogenesis WP2855,0.7615962660023644,0.7335905309293231,0.19978509031519953,"['RET', 'ASCL1']",0.9967659009132112,0,0,2
391,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.7615962660023644,0.7335905309293231,0.19978509031519953,"['CD81', 'PTEN']",0.9967659009132112,0,0,2
392,Type II diabetes mellitus WP1584,0.7615962660023644,0.7335905309293231,0.19978509031519953,"['IRS1', 'PRKCD']",0.9967659009132112,0,0,2
393,Autophagy WP4923,0.7654548376054991,0.762799590303858,0.2038849364548692,"['BECN1', 'UVRAG', 'PRKAG1', 'WIPI2']",0.9967659009132112,0,0,4
394,Trans-sulfuration and one-carbon metabolism WP2525,0.7654548376054991,0.762799590303858,0.2038849364548692,"['BHMT', 'AHCYL1', 'GSS', 'AMT']",0.9967659009132112,0,0,4
395,Circadian rhythm related genes WP3594,0.7662394989937504,0.874882368639128,0.23294661362403377,"['GSK3B', 'SUV39H1', 'PTEN', 'RORA', 'ADCY1', 'ATOH7', 'AANAT', 'NOCT', 'DRD1', 'PRKCG', 'PRMT5', 'NCOA2', 'KCND2', 'DYRK1A', 'PROX1', 'CARTPT', 'MAPK10', 'PER3', 'MYBBP1A', 'PSPC1', 'THRAP3', 'CRY2', 'PPARG', 'TOP1', 'ATF5', 'CLOCK', 'ATF4']",0.9967659009132112,0,0,27
396,Differentiation Pathway WP2848,0.772107136101759,0.7688833068922969,0.19885779763560085,"['ALK', 'IL11', 'NT5E', 'FGF1', 'FGF10']",0.9967659009132112,0,0,5
397,Kit receptor signaling pathway WP304,0.7777596798130525,0.7943589743589744,0.1996523554953516,"['PRKCB', 'STAT1', 'INPP5D', 'FOS', 'MAPT', 'JAK2', 'SOS1', 'VAV1']",0.9967659009132112,0,0,8
398,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7794854621106291,0.7729711262338526,0.19256352617293773,"['MAP2K4', 'HSP90AA1', 'TRAF6', 'TRAF5', 'TRAF2', 'FOS']",0.9967659009132112,0,0,6
399,TGF-beta Receptor Signaling WP560,0.7794854621106291,0.7729711262338526,0.19256352617293773,"['TGFBR3', 'ZEB2', 'STAT1', 'FOS', 'LTBP1', 'NFKB1']",0.9967659009132112,0,0,6
400,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.7819626305160091,0.6812512180861431,0.16755259711151377,['TRAF6'],0.9967659009132112,0,0,1
401,Heme Biosynthesis WP561,0.7819626305160091,0.6812512180861431,0.16755259711151377,['ALAD'],0.9967659009132112,0,0,1
402,HIF1A and PPARG regulation of glycolysis WP2456,0.7819626305160091,0.6812512180861431,0.16755259711151377,['PPARG'],0.9967659009132112,0,0,1
403,Irinotecan pathway WP229,0.7819626305160091,0.6812512180861431,0.16755259711151377,['CES2'],0.9967659009132112,0,0,1
404,NAD Biosynthesis II (from tryptophan) WP2485,0.7819626305160091,0.6812512180861431,0.16755259711151377,['AFMID'],0.9967659009132112,0,0,1
405,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7819626305160091,0.6812512180861431,0.16755259711151377,['NFKB1'],0.9967659009132112,0,0,1
406,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7875116899218059,0.7151365187713311,0.17082971199715594,"['CASP9', 'SESN3', 'PTEN']",0.9967659009132112,0,0,3
407,Sphingolipid Metabolism (general overview) WP4725,0.7875116899218059,0.7151365187713311,0.17082971199715594,"['ASAH1', 'SGPL1', 'SGMS2']",0.9967659009132112,0,0,3
408,Oxidation by Cytochrome P450 WP43,0.7929705513600283,0.7448023394808743,0.17277119821074502,"['CYB5R1', 'CYP4X1', 'CYB5R3', 'CYP24A1', 'CYP20A1']",0.9967659009132112,0,0,5
409,Cancer immunotherapy by PD-1 blockade WP4585,0.7929729665294794,0.6811424672223034,0.1580019943983258,"['ZAP70', 'NFKB1']",0.9967659009132112,0,0,2
410,SARS coronavirus and innate immunity WP4912,0.7929729665294794,0.6811424672223034,0.1580019943983258,"['STAT1', 'IFNAR1']",0.9967659009132112,0,0,2
411,Serotonin and anxiety WP3947,0.7929729665294794,0.6811424672223034,0.1580019943983258,"['PRKCB', 'FOS']",0.9967659009132112,0,0,2
412,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7946228051645937,0.7942182689018132,0.18258103959385952,"['CASP9', 'MAPK10', 'GSK3B', 'AKT3', 'RAC2', 'BRAF', 'RAC1', 'FOS', 'PTGS2', 'RHOA']",0.9967659009132112,0,0,10
413,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7946228051645937,0.7942182689018132,0.18258103959385952,"['GSK3B', 'WNT10B', 'PORCN', 'WNT10A', 'CCND2', 'CSNK2A1', 'ROR1', 'NOTUM', 'CXXC4', 'DKK2']",0.9967659009132112,0,0,10
414,Pathways in clear cell renal cell carcinoma WP4018,0.7966459597804462,0.8053194208041815,0.18308527524631613,"['PDGFRB', 'PBRM1', 'ZEB1', 'EFCAB3', 'PTEN', 'PLOD2', 'VHL', 'RAPGEF5', 'SQSTM1', 'ACACB', 'ACACA', 'PFKP']",0.9967659009132112,0,0,12
415,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8042845354648607,0.7582100913440626,0.16513980516608096,"['VAV3', 'HELLS', 'NRG1', 'TRAF1', 'SQSTM1', 'NFKB1', 'HSPD1']",0.9967659009132112,0,0,7
416,Cardiac Progenitor Differentiation WP2406,0.8103350055288517,0.7061947574067752,0.14851807495018646,"['MESP2', 'GSK3B', 'NRG1', 'SCN5A']",0.9967659009132112,0,0,4
417,"GPCRs, Other WP117",0.8104369893704665,0.7624752136752136,0.1602583242200823,"['GPR143', 'ALG6', 'CCKBR', 'ADGRF5', 'GPR61', 'ADRA1D', 'CELSR3', 'MCHR2']",0.9967659009132112,0,0,8
418,Signal Transduction of S1P Receptor WP26,0.8117138787297311,0.6810336421257923,0.14206863493070596,"['ASAH1', 'PLCB3', 'AKT3']",0.9967659009132112,0,0,3
419,Sphingolipid Metabolism (integrated pathway) WP4726,0.8117138787297311,0.6810336421257923,0.14206863493070596,"['ASAH1', 'SGPL1', 'SGMS2']",0.9967659009132112,0,0,3
420,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.8117138787297311,0.6810336421257923,0.14206863493070596,"['STAT1', 'TRAF6', 'IFNAR1']",0.9967659009132112,0,0,3
421,Hematopoietic Stem Cell Differentiation WP2849,0.8123064388842208,0.722180824639841,0.15012523264252617,"['GYPA', 'MYB', 'ZNF835', 'FOS', 'VAV1']",0.9967659009132112,0,0,5
422,Lung fibrosis WP3624,0.8123064388842208,0.722180824639841,0.15012523264252617,"['TERT', 'ELN', 'FAM13A', 'TGFA', 'FGF1']",0.9967659009132112,0,0,5
423,Vitamin A and carotenoid metabolism WP716,0.8123064388842208,0.722180824639841,0.15012523264252617,"['RXRB', 'SULT1A1', 'SDR16C5', 'RBP4', 'LPL']",0.9967659009132112,0,0,5
424,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.815926683870383,0.7822387038115378,0.1591314267312723,"['GSK3B', 'WNT10B', 'CDK8', 'PORCN', 'WNT10A', 'CCND2', 'CSNK2A1', 'ROR1', 'NOTUM', 'CXXC4', 'DKK2']",0.9967659009132112,0,0,11
425,Male infertility WP4673,0.8191646088308376,0.802843258812023,0.16014332767550116,"['PRMT6', 'DDX4', 'UBE2B', 'XRCC4', 'PARP1', 'XRCC5', 'PEX10', 'CDC42BPA', 'BHMT', 'CAT', 'ERCC2', 'MOV10L1', 'HORMAD1', 'CLOCK', 'SOX5']",0.9967659009132112,0,0,15
426,Bile acids synthesis and enterohepatic circulation  WP4389,0.8197715184630752,0.5960521828103683,0.11845321995788075,['ABCB11'],0.9967659009132112,0,0,1
427,Cytosine methylation WP3585,0.8197715184630752,0.5960521828103683,0.11845321995788075,['IDH2'],0.9967659009132112,0,0,1
428,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.8197715184630752,0.5960521828103683,0.11845321995788075,['E2F1'],0.9967659009132112,0,0,1
429,NLR Proteins WP288,0.8197715184630752,0.5960521828103683,0.11845321995788075,['ERBIN'],0.9967659009132112,0,0,1
430,Role of Osx and miRNAs in tooth development WP3971,0.8197715184630752,0.5960521828103683,0.11845321995788075,['ALPL'],0.9967659009132112,0,0,1
431,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.8197715184630752,0.5960521828103683,0.11845321995788075,['CCND2'],0.9967659009132112,0,0,1
432,Tamoxifen metabolism WP691,0.8197715184630752,0.5960521828103683,0.11845321995788075,['SULT1A1'],0.9967659009132112,0,0,1
433,Cardiac Hypertrophic Response WP2795,0.8204200254519066,0.7413078149920255,0.1467336117297541,"['GSK3B', 'MAP2K4', 'CDK7', 'NPPA', 'NRG1', 'RAC1', 'NFKB1']",0.9967659009132112,0,0,7
434,GDNF/RET signaling axis WP4830,0.8206389946211764,0.6356874786762198,0.12565760286194888,"['RET', 'IFT27']",0.9967659009132112,0,0,2
435,Proteoglycan biosynthesis WP4784,0.8206389946211764,0.6356874786762198,0.12565760286194888,"['B3GALT6', 'B4GALT7']",0.9967659009132112,0,0,2
436,Pyrimidine metabolism and related diseases WP4225,0.8206389946211764,0.6356874786762198,0.12565760286194888,"['RRM2', 'TK2']",0.9967659009132112,0,0,2
437,Amino Acid metabolism WP3925,0.8286980208734493,0.7706798325079518,0.14481032386821857,"['BHMT', 'WARS', 'MDH2', 'RARS', 'MARS2', 'GSS', 'IARS', 'DLD', 'FTCD', 'GLS', 'SRM']",0.9967659009132112,0,0,11
438,Glycogen Synthesis and Degradation WP500,0.8301694351050535,0.7008899871423979,0.13045347150749917,"['GYS2', 'GSK3B', 'PPP2CB', 'PPP2R5A', 'PHKA1']",0.9967659009132112,0,0,5
439,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8301694351050535,0.7008899871423979,0.13045347150749917,"['NFKBIA', 'PIK3CA', 'STAT1', 'JAK2', 'NFKB1']",0.9967659009132112,0,0,5
440,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8304560003069001,0.7523219814241486,0.13976662679915902,"['PTPRT', 'PDGFRB', 'MAPK10', 'PRKCB', 'IFNGR2', 'RICTOR', 'JAK2', 'JAK3', 'IFNAR1']",0.9967659009132112,0,0,9
441,MTHFR deficiency WP4288,0.8335382631879954,0.6500310269934844,0.11835483554111932,"['CASP9', 'BHMT', 'EHMT2']",0.9967659009132112,0,0,3
442,Modulators of TCR signaling and T cell activation WP5072,0.8354965025765441,0.7251404202205117,0.13032884741269052,"['GNA13', 'NFKBIA', 'ITK', 'ZAP70', 'TRAF6', 'VAV1', 'NFKB1']",0.9967659009132112,0,0,7
443,Integrated breast cancer pathway WP1984,0.8378953748865131,0.8129690431519699,0.14378336120550608,"['UBE2F', 'IRS1', 'RALGAPA1', 'STAT1', 'ZMYND8', 'DCAKD', 'PTEN', 'BRAF', 'JAKMIP1', 'CCNB1IP1', 'NFKB1', 'CASP9', 'CDC42', 'CDK7', 'FER', 'PAK1', 'RAP1A', 'CHEK1', 'E2F1', 'RHO', 'RAC1']",0.9967659009132112,0,0,21
444,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8434710819889687,0.7392978442379358,0.12585042135836516,"['ITGB1', 'RYR2', 'ITGA10', 'ITGA8', 'ITGB8', 'ITGAV', 'DSG2', 'SLC8A1', 'CACNG5']",0.9967659009132112,0,0,9
445,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8449375898794533,0.5959143636983965,0.10040710836450953,"['TRAF6', 'NFKB1']",0.9967659009132112,0,0,2
446,Kynurenine Pathway and links to Cellular Senescence WP5044,0.8449375898794533,0.5959143636983965,0.10040710836450953,"['EIF2AK1', 'AFMID']",0.9967659009132112,0,0,2
447,Nanomaterial induced apoptosis WP2507,0.8449375898794533,0.5959143636983965,0.10040710836450953,"['CASP9', 'CASP6']",0.9967659009132112,0,0,2
448,Nicotine Activity on Dopaminergic Neurons WP1602,0.8449375898794533,0.5959143636983965,0.10040710836450953,"['GNB1', 'PRKACA']",0.9967659009132112,0,0,2
449,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8449375898794533,0.5959143636983965,0.10040710836450953,"['SUV39H1', 'ECSIT']",0.9967659009132112,0,0,2
450,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8466219003134918,0.680815768930523,0.1133565626332344,"['CASP9', 'NFKBIA', 'CAMK2A', 'NPPA', 'NFKB1']",0.9967659009132112,0,0,5
451,BDNF-TrkB Signaling WP3676,0.8479329343356821,0.6573974876679106,0.1084401697779618,"['GAB1', 'BRAF', 'ADCY1', 'SOS1']",0.9967659009132112,0,0,4
452,CAMKK2  Pathway WP4874,0.8479329343356821,0.6573974876679106,0.1084401697779618,"['MAF', 'RAC1', 'SQSTM1', 'CAMKK2']",0.9967659009132112,0,0,4
453,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8479329343356821,0.6573974876679106,0.1084401697779618,"['IGFBP2', 'TGFA', 'HIF1AN', 'PTGS2']",0.9967659009132112,0,0,4
454,Type 2 papillary renal cell carcinoma WP4241,0.8479329343356821,0.6573974876679106,0.1084401697779618,"['CUL2', 'TGFA', 'VHL', 'RBX1']",0.9967659009132112,0,0,4
455,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.8510259274621575,0.5297862664847658,0.08546124449753464,['ERBB2'],0.9967659009132112,0,0,1
456,Nanoparticle triggered regulated necrosis WP2513,0.8510259274621575,0.5297862664847658,0.08546124449753464,['PARP1'],0.9967659009132112,0,0,1
457,Selective expression of chemokine receptors during T-cell polarization WP4494,0.8510259274621575,0.5297862664847658,0.08546124449753464,['IFNGR2'],0.9967659009132112,0,0,1
458,Valproic acid pathway WP3871,0.8510259274621575,0.5297862664847658,0.08546124449753464,['IVD'],0.9967659009132112,0,0,1
459,Metapathway biotransformation Phase I and II WP702,0.8517154446985247,0.7859616178566197,0.12614903488342474,"['GSTK1', 'GAL3ST1', 'GPX3', 'NAA20', 'MGST3', 'GSS', 'AKR1A1', 'KCNAB3', 'HS3ST1', 'NAA80', 'SULT1A1', 'GSTZ1', 'AKR7A2', 'CYP4X1', 'CYP24A1', 'GSTA4', 'CYP20A1']",0.9967659009132112,0,0,17
460,TNF-alpha signaling pathway WP231,0.8565984477478226,0.7520676048217085,0.11640955576679483,"['CASP9', 'NFKBIA', 'MAP2K4', 'HSP90AA1', 'CSNK2A1', 'TRAF2', 'TAB2', 'RAC1', 'TRAF1', 'SOS1', 'NFKB1', 'NFKBIB']",0.9967659009132112,0,0,12
461,Adipogenesis WP236,0.8603645175939182,0.7680912688761635,0.11552025235462289,"['NCOA1', 'WNT10B', 'NCOA2', 'MBNL1', 'EGR2', 'IRS1', 'STAT1', 'LPL', 'RORA', 'NR3C1', 'KLF6', 'E2F1', 'SPOCK1', 'PPARG', 'LPIN3']",0.9967659009132112,0,0,15
462,Target Of Rapamycin (TOR) Signaling WP1471,0.8642397014342545,0.6354387162854217,0.09271375988992415,"['CDC42', 'PRKAG1', 'RICTOR', 'RAC1']",0.9967659009132112,0,0,4
463,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.8662045174124694,0.5608204387179642,0.08055301469211597,"['PTEN', 'ZFX']",0.9967659009132112,0,0,2
464,Imatinib and Chronic Myeloid Leukemia WP3640,0.8662045174124694,0.5608204387179642,0.08055301469211597,"['PDGFRB', 'SKP2']",0.9967659009132112,0,0,2
465,miRNA targets in ECM and membrane receptors WP2911,0.8662045174124694,0.5608204387179642,0.08055301469211597,"['COL5A1', 'LAMC1']",0.9967659009132112,0,0,2
466,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.8662045174124694,0.5608204387179642,0.08055301469211597,"['NFKBIA', 'NFKB1']",0.9967659009132112,0,0,2
467,Ethanol effects on histone modifications WP3996,0.8707058217321961,0.5957764505119454,0.08248590904040062,"['KAT2B', 'ACSS2', 'EHMT2']",0.9967659009132112,0,0,3
468,Monoamine GPCRs WP58,0.8707058217321961,0.5957764505119454,0.08248590904040062,"['HTR1E', 'ADRA1D', 'DRD1']",0.9967659009132112,0,0,3
469,Cells and molecules involved in local acute inflammatory response  WP4493,0.8768618074280748,0.47677353342428375,0.06265084248989619,['ITGB1'],0.9967659009132112,0,0,1
470,Glycolysis in senescence WP5049,0.8768618074280748,0.47677353342428375,0.06265084248989619,['G6PD'],0.9967659009132112,0,0,1
471,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.8768618074280748,0.47677353342428375,0.06265084248989619,['ZAP70'],0.9967659009132112,0,0,1
472,Oxysterols derived from cholesterol WP4545,0.8790226489014885,0.6148966398308351,0.07928761046352602,"['ACOT8', 'ACOT7', 'ACOT13', 'SLC27A5']",0.9967659009132112,0,0,4
473,Urea cycle and metabolism of amino groups WP497,0.8847603497130294,0.5296258387353576,0.0648465730928787,"['PYCR3', 'SRM']",0.9967659009132112,0,0,2
474,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8863806931490923,0.5719044368600683,0.06897667605846186,"['TGFBR3', 'ERBB2', 'TGFA']",0.9967659009132112,0,0,3
475,Peptide GPCRs WP24,0.8882139972139371,0.6269323410986483,0.07431817542464318,"['NPY5R', 'CCKBR', 'TACR2', 'SSTR1', 'FPR2']",0.9967659009132112,0,0,5
476,Genes targeted by miRNAs in adipocytes WP1992,0.8982182935159385,0.4333994791020712,0.046522032620927765,['PTBP2'],0.9967659009132112,0,0,1
477,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.8982182935159385,0.4333994791020712,0.046522032620927765,['GRM5'],0.9967659009132112,0,0,1
478,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.8982182935159385,0.4333994791020712,0.046522032620927765,['ITGAV'],0.9967659009132112,0,0,1
479,Heart Development WP1591,0.9003336365445667,0.5498687319506432,0.05773065057821065,"['HEY1', 'VEGFC', 'FGF10']",0.9967659009132112,0,0,3
480,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9003336365445667,0.5498687319506432,0.05773065057821065,"['CASP9', 'PIK3CA', 'BRAF']",0.9967659009132112,0,0,3
481,Differentiation of white and brown adipocyte WP2895,0.9009056455645836,0.5017148808561834,0.052356330341614445,"['CIDEA', 'PPARG']",0.9967659009132112,0,0,2
482,Eicosanoid Synthesis WP167,0.9009056455645836,0.5017148808561834,0.052356330341614445,"['PLA2G6', 'PTGS2']",0.9967659009132112,0,0,2
483,Purinergic signaling WP4900,0.9009056455645836,0.5017148808561834,0.052356330341614445,"['PANX1', 'P2RX5']",0.9967659009132112,0,0,2
484,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.9009056455645836,0.5017148808561834,0.052356330341614445,"['GSK3B', 'BCL2L2']",0.9967659009132112,0,0,2
485,MECP2 and Associated Rett Syndrome WP3584,0.9054585235817136,0.65692897141173,0.06524211753774987,"['PRPF38A', 'CAMK2A', 'SP3', 'PTEN', 'E2F1', 'NREP', 'IGF1R', 'FKBP5']",0.9967659009132112,0,0,8
486,Ectoderm Differentiation WP2858,0.9062286639575867,0.7355748846489587,0.07242736320906298,"['ABCC4', 'EDA', 'TSC22D1', 'FZD4', 'ZBTB16', 'HMGB2', 'STC1', 'JAKMIP1', 'VAX2', 'CDH8', 'AHI1', 'PLCXD3', 'ARHGEF9', 'PODXL', 'NF2', 'ANKS1B', 'CAP2']",0.9967659009132112,0,0,17
487,Energy Metabolism WP1541,0.9102103869396129,0.5955003415300546,0.05602438138014369,"['NCOA1', 'GSK3B', 'MYBBP1A', 'PRKAG1', 'PPARG']",0.9967659009132112,0,0,5
488,GABA receptor Signaling WP4159,0.9127207983417591,0.5294653014789533,0.0483535520882272,"['GABRQ', 'GABRB1', 'GABRA3']",0.9967659009132112,0,0,3
489,Sleep regulation WP3591,0.9127207983417591,0.5294653014789533,0.0483535520882272,"['PER3', 'DRD1', 'FOS']",0.9967659009132112,0,0,3
490,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.914918256472596,0.47659501876492666,0.0423790935244045,"['PLA2G6', 'PTGS2']",0.9967659009132112,0,0,2
491,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.914918256472596,0.47659501876492666,0.0423790935244045,"['ABCC4', 'FOS']",0.9967659009132112,0,0,2
492,Prostaglandin Synthesis and Regulation WP98,0.9152764202983874,0.5605205550981062,0.049622414265688766,"['CBR1', 'ABCC4', 'PPARG', 'PTGS2']",0.9967659009132112,0,0,4
493,GPR40 Pathway WP3958,0.9158717968906605,0.3972544338335607,0.03491027624166749,['PLCB3'],0.9967659009132112,0,0,1
494,Hedgehog Signaling Pathway Netpath WP47,0.9158717968906605,0.3972544338335607,0.03491027624166749,['STK36'],0.9967659009132112,0,0,1
495,Homologous recombination WP186,0.9158717968906605,0.3972544338335607,0.03491027624166749,['POLD1'],0.9967659009132112,0,0,1
496,Omega-3/Omega-6 FA synthesis WP4723,0.9158717968906605,0.3972544338335607,0.03491027624166749,['PLA2G6'],0.9967659009132112,0,0,1
497,TYROBP causal network in microglia WP3945,0.9197126825299913,0.5809342929494868,0.048620691077748926,"['ABCC4', 'CD84', 'MAF', 'CREB3L2', 'SFT2D2']",0.9967659009132112,0,0,5
498,The influence of laminopathies on Wnt signaling WP4844,0.9236906654052379,0.5105192588980985,0.0405240187105479,"['GSK3B', 'WNT10B', 'PPARG']",0.9967659009132112,0,0,3
499,DNA Mismatch Repair WP531,0.9270521668141739,0.4538675244918848,0.03437839539845281,"['RFC2', 'POLD1']",0.9967659009132112,0,0,2
500,Airway smooth muscle cell contraction WP4962,0.9304641917641614,0.3666701647602057,0.02642653713784777,['RHOA'],0.9967659009132112,0,0,1
501,Cell Differentiation - Index expanded WP2023,0.9304641917641614,0.3666701647602057,0.02642653713784777,['PAX7'],0.9967659009132112,0,0,1
502,Fatty acid transporters WP5061,0.9304641917641614,0.3666701647602057,0.02642653713784777,['FABP7'],0.9967659009132112,0,0,1
503,Kennedy pathway from sphingolipids WP3933,0.9304641917641614,0.3666701647602057,0.02642653713784777,['SGPL1'],0.9967659009132112,0,0,1
504,Mammalian disorder of sexual development WP4842,0.9304641917641614,0.3666701647602057,0.02642653713784777,['SRD5A1'],0.9967659009132112,0,0,1
505,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.9304641917641614,0.3666701647602057,0.02642653713784777,['SAMHD1'],0.9967659009132112,0,0,1
506,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9333829457102905,0.4928798399435095,0.0339789965730262,"['NFKBIA', 'NELFA', 'NFKB1']",0.9967659009132112,0,0,3
507,Folate Metabolism WP176,0.9360847216346416,0.5538346676833142,0.0365803877042669,"['FLAD1', 'GPX3', 'CAT', 'APOA1', 'NFKB1']",0.9967659009132112,0,0,5
508,Gastric Cancer Network 1 WP2361,0.9375374181056951,0.4332061660618467,0.027941195245968924,"['CENPF', 'MCM4']",0.9967659009132112,0,0,2
509,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.9375374181056951,0.4332061660618467,0.027941195245968924,"['ASCL1', 'SOX5']",0.9967659009132112,0,0,2
510,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9375374181056951,0.4332061660618467,0.027941195245968924,"['GSK3B', 'ZBTB16']",0.9967659009132112,0,0,2
511,Cholesterol Biosynthesis Pathway WP197,0.9425261216609833,0.3404550769830442,0.020152095971430067,['LSS'],0.9967659009132112,0,0,1
512,ERK Pathway in Huntington's Disease WP3853,0.9425261216609833,0.3404550769830442,0.020152095971430067,['RPS6KA5'],0.9967659009132112,0,0,1
513,miRNAs involved in DNA damage response WP1545,0.9425261216609833,0.3404550769830442,0.020152095971430067,['E2F1'],0.9967659009132112,0,0,1
514,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9425261216609833,0.3404550769830442,0.020152095971430067,['DLD'],0.9967659009132112,0,0,1
515,Tryptophan catabolism leading to NAD+ production WP4210,0.9425261216609833,0.3404550769830442,0.020152095971430067,['AFMID'],0.9967659009132112,0,0,1
516,DNA damage response WP707,0.943102334942194,0.5847393603626291,0.03425431335176381,"['CASP9', 'CCND2', 'CHEK1', 'E2F1', 'CDK1', 'RAD1', 'ATRIP']",0.9967659009132112,0,0,7
517,Ovarian infertility WP34,0.946580776114161,0.4143414474952902,0.022746918723989536,"['CCND2', 'DMC1']",0.9967659009132112,0,0,2
518,Complement system WP2806,0.9469084965880344,0.5950854700854701,0.032463587544216126,"['LAMA5', 'F11', 'APOA1', 'CALR', 'LAMC1', 'PRKACA', 'KLKB1', 'ELANE']",0.9967659009132112,0,0,8
519,Allograft Rejection WP2328,0.949395499005852,0.529143897996357,0.02747834407464945,"['CASP9', 'COL5A1', 'GNLY', 'STAT1', 'BHMT2']",0.9967659009132112,0,0,5
520,Pre-implantation embryo WP3527,0.9494460843208861,0.4610150831223164,0.023915864437887086,"['BATF3', 'E2F5', 'NR3C2']",0.9967659009132112,0,0,3
521,Glycosaminoglycan degradation WP4815,0.9524962689758395,0.3177353342428377,0.015463889284439678,['GNS'],0.9967659009132112,0,0,1
522,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9524962689758395,0.3177353342428377,0.015463889284439678,['SIRT6'],0.9967659009132112,0,0,1
523,miRNA regulation of DNA damage response WP1530,0.9538781362550671,0.5648365907063498,0.02667121975780212,"['CASP9', 'CCND2', 'CHEK1', 'E2F1', 'CDK1', 'RAD1', 'ATRIP']",0.9967659009132112,0,0,7
524,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9543668860080285,0.39704878880928013,0.0185449994436735,"['THRA', 'STAT1']",0.9967659009132112,0,0,2
525,Toll-like Receptor Signaling related to MyD88 WP3858,0.9543668860080285,0.39704878880928013,0.0185449994436735,"['TRAF6', 'NFKB1']",0.9967659009132112,0,0,2
526,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9546088477370205,0.48848386164876434,0.022691836809799158,"['BECN1', 'WIPI2', 'PLA2G6', 'ACACA']",0.9967659009132112,0,0,4
527,Oxidative phosphorylation WP623,0.9550592957213853,0.5176036469470183,0.023800373599276666,"['NDUFB6', 'NDUFS1', 'NDUFV3', 'NDUFV1', 'ATP5MG']",0.9967659009132112,0,0,5
528,IL-18 signaling pathway WP4754,0.9565428674361854,0.7291530018802747,0.032396030265545925,"['MTCH1', 'GSK3B', 'TOMM40', 'EPB41', 'CD81', 'HSPB8', 'PTEN', 'PTGS2', 'ACACB', 'RXRB', 'NPPA', 'ABCF1', 'CA11', 'PARP1', 'PRKCB', 'ECH1', 'PRKCD', 'HPS1', 'FOS', 'TRAF1', 'NFKB1', 'NFKBIA', 'SLC4A7', 'ACTA1', 'ALS2', 'TRAF6', 'LTB', 'PTPN7', 'CDK5R2']",0.9967659009132112,0,0,29
529,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.960138492913557,0.5065544704104173,0.020605491789653485,"['GSK3B', 'KAT2B', 'WNT10B', 'E2F1', 'PPARG']",0.9967659009132112,0,0,5
530,"GPCRs, Class B Secretin-like WP334",0.9607372872425456,0.2978555593451569,0.01193039049267568,['ADGRE5'],0.9967659009132112,0,0,1
531,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9607372872425456,0.2978555593451569,0.01193039049267568,['CPT2'],0.9967659009132112,0,0,1
532,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.9607372872425456,0.2978555593451569,0.01193039049267568,['TNC'],0.9967659009132112,0,0,1
533,Endothelin Pathways WP2197,0.9668042235798748,0.3664540849801853,0.012371219298844948,"['NPY', 'GNB5']",0.9967659009132112,0,0,2
534,Glycerophospholipid Biosynthetic Pathway WP2533,0.9668042235798748,0.3664540849801853,0.012371219298844948,"['PIK3CA', 'PIK3CD']",0.9967659009132112,0,0,2
535,Hedgehog Signaling Pathway WP4249,0.9669000897300257,0.42024693836579,0.014145557622400102,"['CCND2', 'SMURF2', 'PRKACA']",0.9967659009132112,0,0,3
536,Proximal tubule transport WP4917,0.9692725583203541,0.45349461054479834,0.014153307716448911,"['ABCC4', 'SLC47A1', 'SLC3A2', 'SLC4A2']",0.9967659009132112,0,0,4
537,Selenium Micronutrient Network WP15,0.9701005693044035,0.5288220551378446,0.01605267543249384,"['PRDX4', 'FLAD1', 'GPX3', 'CAT', 'APOA1', 'PTGS2', 'NFKB1']",0.9967659009132112,0,0,7
538,Ferroptosis WP4313,0.9713249407247662,0.4082106289614822,0.011876570347241867,"['GSS', 'LPCAT3', 'SLC3A2']",0.9967659009132112,0,0,3
539,Vitamin B12 metabolism WP1533,0.9713249407247662,0.4082106289614822,0.011876570347241867,"['CUBN', 'APOA1', 'NFKB1']",0.9967659009132112,0,0,3
540,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9731791649862912,0.26472260118235563,0.00719703376068783,['CASP9'],0.9967659009132112,0,0,1
541,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9731791649862912,0.26472260118235563,0.00719703376068783,['BECN1'],0.9967659009132112,0,0,1
542,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.9731791649862912,0.26472260118235563,0.00719703376068783,['RASGRP1'],0.9967659009132112,0,0,1
543,Prion disease pathway WP3995,0.9759426814575782,0.3402300531266754,0.008285085705689674,"['PDIA3', 'NFKB1']",0.9967659009132112,0,0,2
544,Synaptic Vesicle Pathway WP2267,0.9764460147382016,0.43281914398336385,0.010316596888601022,"['NAPA', 'STXBP1', 'CLTA', 'STX1A']",0.9967659009132112,0,0,4
545,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.9778327313800363,0.250771881955913,0.0056214667323161195,['H2AFY'],0.9967659009132112,0,0,1
546,Neovascularisation processes WP4331,0.9795462283124448,0.3284744526406193,0.006788202743686288,"['DLL4', 'NFKB1']",0.9967659009132112,0,0,2
547,Angiogenesis WP1539,0.9816790321073802,0.2382162346521146,0.004404826682158419,['PIK3CA'],0.9967659009132112,0,0,1
548,Glycerolipids and Glycerophospholipids WP4722,0.9816790321073802,0.2382162346521146,0.004404826682158419,['DGAT2'],0.9967659009132112,0,0,1
549,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9848580649977108,0.2268563632820113,0.003461316461361435,['FPR2'],0.9967659009132112,0,0,1
550,Urea cycle and associated pathways WP4595,0.9848580649977108,0.2268563632820113,0.003461316461361435,['MDH2'],0.9967659009132112,0,0,1
551,p53 transcriptional gene network WP4963,0.985329643711855,0.432625434674615,0.006393784334313247,"['XRCC5', 'SESN2', 'PTEN', 'FANCC', 'ISG15']",0.9967659009132112,0,0,5
552,Interleukin-11 Signaling Pathway WP2332,0.9862199789207979,0.35705631399317406,0.004954458750996915,"['IL11', 'STAT1', 'JAK2']",0.9967659009132112,0,0,3
553,Genotoxicity pathway WP4286,0.9863302163642982,0.39663707750085353,0.005459342646269896,"['HIST1H2BN', 'SEL1L', 'RAPGEF2', 'PPM1D']",0.9967659009132112,0,0,4
554,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9874855559737138,0.21652920749100832,0.0027268409084666863,['PRKACA'],0.9967659009132112,0,0,1
555,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9881314474400493,0.3483226504619995,0.004158814348498209,"['SOAT1', 'LSS', 'TM7SF2']",0.9967659009132112,0,0,3
556,Vitamin D Receptor Pathway WP2877,0.9896461444781168,0.5380555896468643,0.005599990874534982,"['G6PD', 'STS', 'CYP24A1', 'COL13A1', 'ADGRE5', 'TPM1', 'CREG2', 'CLPTM1L', 'EFNA5', 'RASGRP1', 'SLC8A1', 'CD200']",0.9967659009132112,0,0,12
557,22q11.2 copy number variation syndrome WP4657,0.9916398440995248,0.4862151784603905,0.004081921316846871,"['CDC42', 'AIFM3', 'HIRIP3', 'HIST1H4C', 'TNPO1', 'SNAP29', 'HIST1H4E', 'RBX1', 'FGF10']",0.996980812739199,0,0,9
558,Complement and Coagulation Cascades WP558,0.9976609732197085,0.2265925817614661,0.0005306269344675593,"['F8', 'KLKB1']",0.9999962927532052,0,0,2
559,"GPCRs, Class A Rhodopsin-like WP455",0.9998278091686537,0.3557370041039672,6.125992482738564e-05,"['CCKBR', 'HTR1E', 'NPY5R', 'RHO', 'RRH', 'ADRA1D', 'FPR2', 'DRD1', 'SSTR1']",0.9999962927532052,0,0,9
560,Cytoplasmic Ribosomal Proteins WP477,0.9999962927532052,0.05513737745486849,2.0440824473776522e-07,['RPS6KA2'],0.9999962927532052,0,0,1
